<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Protocols — NAEOTOM Connect</title>
        <link>https://connect.siemens-healthineers.com/en/</link>
        <pubDate>Sun, 25 Oct 2026 02:45:12 +0000</pubDate>
        <language>en</language>
            <description>Protocols — NAEOTOM Connect</description>
    <atom:link href="https://connect.siemens-healthineers.com/en/discussions/tagged/protocols/feed.rss" rel="self" type="application/rss+xml"/>
    <item>
        <title>(2025) Braaksma | Pediatric abdomen PCCT protocol development</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/604/2025-braaksma-pediatric-abdomen-pcct-protocol-development</link>
        <pubDate>Sat, 24 Oct 2026 13:00:19 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">604@/en/discussions</guid>
        <description><![CDATA[<div><div><p>For routine pediatric abdomen PCCT, start with Quantum mode at 70 kV and low-keV VMI rather than defaulting to QuantumPlus. Based on their phantom work, the authors favor the lowest tube voltage as the ALARA-oriented starting point, and for their standard protocol they selected 70 kV Quantum mode with VMI 53 keV.</p><p><br />
Optimize image quality first through reconstruction settings before increasing acquisition dose. The authors recommend first adjusting QIR strength, kernel choice, and windowing if noise is too high, and only then considering higher IQ level, DAC changes, or QuantumPlus mode.</p><p><br />
Use high-pitch FLASH selectively, not routinely. The authors found FLASH shortened scan time but slightly increased noise and dose, so they recommend it mainly for children who cannot hold their breath long enough for a standard scan.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00247-025-06274-7" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/2T3J4MAENTLK\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:884483,&quot;width&quot;:2032,&quot;height&quot;:530,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F2T3J4MAENTLK%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1288,&quot;dateInserted&quot;:&quot;2026-04-10T14:10:53+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:&quot;embed&quot;,&quot;foreignID&quot;:&quot;14&quot;,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F2T3J4MAENTLK%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/2T3J4MAENTLK/image.png" alt="image.png" height="530" width="2032" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/2T3J4MAENTLK/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/2T3J4MAENTLK/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/2T3J4MAENTLK/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/2T3J4MAENTLK/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/2T3J4MAENTLK/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/2T3J4MAENTLK/image.png 2000w, https://us.v-cdn.net/6038601/uploads/2T3J4MAENTLK/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 5. </strong>Examples of the clinical implementation of the pediatric abdomen protocol. Axial computed tomography slices in the portal venous phase after intravenous contrast demonstrate the appearances of contrast and noise of the protocol at different ages. Protocol: 70 kV Quantum mode at 53 keV virtual monoenergetic image, IQ level 120, body reconstruction kernel 40, quantum iterative reconstruction 2, 1.0-mm slice thickness. a Six-month-old girl after liver transplantation. b Two-year-old girl prior to liver transplantation. c Six-year-old boy after liver transplantation</p><p><em>Source note for image: Braaksma et al.,</em> Pediatric Radiology, <em>2025.</em></p><p></p><h2 data-id="standard-protocol"><strong>Standard Protocol</strong></h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Parameter</p></th><td><p></p></td></tr><tr><th><p>Scanner</p></th><td><p>NAEOTOM Alpha</p></td></tr><tr><th><p>Scan mode</p></th><td><p>Quantum</p></td></tr><tr><th><p>Siemens protocol</p></th><td><p>RoutineFlashSpiralChildAbdomenQuantum</p></td></tr><tr><th><p>Tube voltage, kV</p></th><td><p>70/90</p></td></tr><tr><th><p>Number of slices, mm</p></th><td><p>144 × 0.4</p></td></tr><tr><th><p>Z-coverage, mm</p></th><td><p>58</p></td></tr><tr><th><p>Rotation time, s</p></th><td><p>0.25</p></td></tr><tr><th><p>IQ level</p></th><td><p>120</p></td></tr><tr><th><p>Pitch</p></th><td><p>3.2 (FLASH) or 1.5</p></td></tr><tr><th><p>Care keV</p></th><td><p>On</p></td></tr><tr><th><p>CARE Dose4D</p></th><td><p>On</p></td></tr><tr><th><p>Dose adaption curve</p></th><td><p>Average</p></td></tr><tr><th><p>Tissue of interest setting</p></th><td><p>Soft tissue with contrast</p></td></tr></table></div><h4 data-id="n-a"><strong></strong></h4><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Reconstruction parameters</p></th><td><p></p></td></tr><tr><th><p>Reconstructed slice thickness, mm</p></th><td><p>1.0 and 3.0 (0.6 and 2.0 increment)</p></td></tr><tr><th><p>Matrix</p></th><td><p>Auto</p></td></tr><tr><th><p>VMI, keV</p></th><td><p>53</p></td></tr><tr><th><p>Kernels</p></th><td><p>Br40 (1 mm), Br40 (3 mm)</p></td></tr><tr><th><p>QIR</p></th><td><p>2</p></td></tr><tr><th><p>Window level / window width</p></th><td><p>55 / 335</p></td></tr><tr><th><p>Spectral analysis</p></th><td><p>No</p></td></tr><tr><th><p></p><p><strong>Intravenous iodine contrast</strong></p></th><td><p></p></td></tr><tr><th><p>Contrast phase</p></th><td><p>Portal venous, delay is age dependent</p></td></tr><tr><th><p>Volume and flow rate</p></th><td><p>Age and kV dependent</p></td></tr></table></div><p></p><h2 data-id="complex-protocol-not-used-clinically-optimized-for-noise-thinner-slices"><strong>Complex Protocol (not used clinically, optimized for noise &amp; thinner slices)</strong></h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Parameter</p></th><td><p><strong>Value</strong></p></td></tr><tr><th><p>Scanner</p></th><td><p>NAEOTOM Alpha</p></td></tr><tr><th><p>Scan mode</p></th><td><p>QuantumPlus</p></td></tr><tr><th><p>Siemens protocol</p></th><td><p>RoutineFlashSpiralChildAbdomenQuantumplus</p></td></tr><tr><th><p>Tube voltage, kV</p></th><td><p>120/140</p></td></tr><tr><th><p>Number of slices, mm</p></th><td><p>144 × 0.4</p></td></tr><tr><th><p>Z-coverage, mm</p></th><td><p>58</p></td></tr><tr><th><p>Rotation time, s</p></th><td><p>0.25</p></td></tr><tr><th><p>IQ level</p></th><td><p>120</p></td></tr><tr><th><p>Pitch</p></th><td><p>3.2 (FLASH) or 1.5</p></td></tr><tr><th><p>Care keV</p></th><td><p>On</p></td></tr><tr><th><p>CARE Dose4D</p></th><td><p>On</p></td></tr><tr><th><p>Dose adaption curve</p></th><td><p>Average</p></td></tr><tr><th><p>Tissue of interest setting</p></th><td><p>Soft tissue with contrast</p></td></tr></table></div><h3 data-id="n-a-1"><strong></strong></h3><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Reconstruction parameters</p></th><td><p></p></td></tr><tr><th><p>Reconstructed slice thickness, mm</p></th><td><p>0.4, 1.0 and 3.0 (0.3, 0.6 and 2.0 increment)</p></td></tr><tr><th><p>Matrix</p></th><td><p>Auto</p></td></tr><tr><th><p>VMI, keV</p></th><td><p>53 (T3D for non-contrast if needed)</p></td></tr><tr><th><p>Kernels</p></th><td><p>Br40 (1 mm), Br40 (3 mm), Bv60 (0.4, 1 mm)</p></td></tr><tr><th><p>QIR</p></th><td><p>2</p></td></tr><tr><th><p>Window level / window width</p></th><td><p>55 / 335</p></td></tr><tr><th><p>Spectral analysis</p></th><td><p>Iodine map, virtual non-contrast</p></td></tr><tr><th><p><strong>Intravenous iodine contrast</strong></p></th><td><p></p></td></tr><tr><th><p>Contrast phase</p></th><td><p>Portal venous, delay is age dependent</p></td></tr><tr><th><p>Volume and flow rate</p></th><td><p>Age and kV dependent</p></td></tr></table></div><p><br />
Source: Braaksma J, Greuter MJW, Verhagen MV. Physics and rationale in pediatric abdomen photon counting detector computed tomography: an investigative review towards development of a pediatric abdomen protocol. <em>Pediatr Radiol.</em> 2025;55:1556–1567. doi:10.1007/s00247-025-06274-7</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Stammen | Contrast media reduction for CTPA using PCCT vs EID-CT</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/603/2026-stammen-contrast-media-reduction-for-ctpa-using-pcct-vs-eid-ct</link>
        <pubDate>Sat, 24 Oct 2026 12:48:00 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">603@/en/discussions</guid>
        <description><![CDATA[<div><div><p>PCCT reduced iodine load by 26.7% and CTDIvol by 24.4% compared to highly individualized EID-CT protocols, confirming real-world dose efficiency even against optimized reference standards. Diagnostic image quality (IQ) remained equivalent, with no significant differences in attenuation or SNR and only a minor, clinically irrelevant CNR reduction proximally.</p><p></p><p>A TBW-adapted CM protocol with fixed 120 kV and 55 keV VMI is sufficient on PCCT, simplifying workflow while enabling contrast and radiation dose savings.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00330-025-12054-6" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/PO5WSECN3UUG\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:260192,&quot;width&quot;:685,&quot;height&quot;:385,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FPO5WSECN3UUG%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1978,&quot;dateInserted&quot;:&quot;2026-10-24T12:46:49+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FPO5WSECN3UUG%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/PO5WSECN3UUG/image.png" alt="image.png" height="385" width="685" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/PO5WSECN3UUG/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/PO5WSECN3UUG/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/PO5WSECN3UUG/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/PO5WSECN3UUG/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/PO5WSECN3UUG/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/PO5WSECN3UUG/image.png 2000w, https://us.v-cdn.net/6038601/uploads/PO5WSECN3UUG/image.png" sizes="100vw" /></a>
    </span>
</span>
<span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/AA9A3CCBDRAP\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1295656,&quot;width&quot;:1350,&quot;height&quot;:1463,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FAA9A3CCBDRAP%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1979,&quot;dateInserted&quot;:&quot;2026-10-24T12:46:57+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FAA9A3CCBDRAP%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/AA9A3CCBDRAP/image.png" alt="image.png" height="1463" width="1350" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/AA9A3CCBDRAP/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/AA9A3CCBDRAP/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/AA9A3CCBDRAP/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/AA9A3CCBDRAP/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/AA9A3CCBDRAP/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/AA9A3CCBDRAP/image.png 2000w, https://us.v-cdn.net/6038601/uploads/AA9A3CCBDRAP/image.png" sizes="100vw" /></a>
    </span>
</span>
<h3 data-id="figure-3">Figure 3</h3><p>Representative CT pulmonary artery scans from both a PCD-CT and an EID-CT. Images A and B were rated by both observers as moderate, and C and D were rated as good by both observers. Images E and F are examples of PE findings for both scanners.</p><h3 data-id="protocol">Protocol</h3><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p>Detail</p></th><th><p>Protocol</p></th></tr><tr><td><p>Scanner</p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p>Scan area</p></td><td><p>Pulmonary arteries (CTPA)</p></td></tr><tr><td><p>Scan mode</p></td><td><p>QuantumPlus </p></td></tr><tr><td><p>Tube voltage [kV]</p></td><td><p>120</p></td></tr><tr><td><p>IQ level</p></td><td><p>70 (CARE keV)</p></td></tr><tr><td><p>Dose modulation</p></td><td><p>CARE Dose4D, CARE keV</p></td></tr><tr><td><p>CTDIvol [mGy]</p></td><td><p>3.4 +/- 1.1</p></td></tr><tr><td><p>DLP [mGy*cm]</p></td><td><p>n.r.</p></td></tr><tr><td><p>Effective dose [mSv]</p></td><td><p>n.r.</p></td></tr><tr><td><p>Rotation time [s]</p></td><td><p>0.25</p></td></tr><tr><td><p>Pitch</p></td><td><p>2.4</p></td></tr><tr><td><p>Slice collimation [mm]</p></td><td><p>144 × 0.4</p></td></tr><tr><td><p>Slice width [mm]</p></td><td><p>1.0</p></td></tr><tr><td><p>Reconstruction increment [mm]</p></td><td><p>0.8</p></td></tr><tr><td><p>Reconstruction kernel</p></td><td><p>Bv40</p></td></tr><tr><td><p>Iterative reconstruction</p></td><td><p>QIR (strength 3)</p></td></tr><tr><td><p>keV level [keV]</p></td><td><p>55 (VMI)</p></td></tr><tr><td><p>Contrast agent</p></td><td><p>Ultravist 300 / 370</p></td></tr><tr><td><p>Contrast volume</p></td><td><p>TBW-adapted (≈10.2 +/- 1.4 g iodine total load)</p></td></tr><tr><td><p>Flow rate</p></td><td><p>n.r. (fixed injection duration around 8 s)</p></td></tr><tr><td><p>Saline chaser</p></td><td><p>40 mL</p></td></tr><tr><td><p>Acquisition phase</p></td><td><p>Pulmonary arterial (test bolus + peak + 7 s)</p></td></tr></table></div><p>Stammen L, Hoeijmakers EJI, Flohr TG, et al. <em>Reducing contrast media dosage for pulmonary embolism CTPA in PCCT</em>. Eur Radiol. 2026;36:3206–3215. doi:10.1007/s00330-025-12054-6</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Gkizas | PCCT-derived ECV quantifies myocardial fibrosis in HCM</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/602/2026-gkizas-pcct-derived-ecv-quantifies-myocardial-fibrosis-in-hcm</link>
        <pubDate>Sat, 24 Oct 2026 07:57:00 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">602@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In 30 patients with genotype-confirmed hypertrophic cardiomyopathy, global PCCT-derived extracellular volume (ECV) closely matched cardiac MRI: 30.0 ± 4.8% vs 30.62 ± 4.2% (p = 0.59), with a small Bland–Altman bias of 0.6% and limits of agreement of −1.49% to 2.75%.</p><p></p><p>Agreement was also strong regionally, with segmental correlations of r = 0.89 at the base and r = 0.85 at both mid-ventricular and apical levels. Interobserver reproducibility was excellent for PCCT-derived ECV (ICC 0.982) and MRI-derived ECV (ICC 0.921).   </p><p></p><p>A global PCCT ECV threshold of 33.4% identified patients with LGE ≥15% with 80% sensitivity and 76% specificity (AUC 0.77). PCCT ECV also correlated with functional and biomarker severity, including peak VO₂ (r = −0.76) and NT-proBNP (r = 0.59), supporting its potential as a combined coronary and myocardial tissue-characterization biomarker. </p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS2211568425001640" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/MX9WJ9HVMLKQ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:591950,&quot;width&quot;:1000,&quot;height&quot;:575,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMX9WJ9HVMLKQ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1976,&quot;dateInserted&quot;:&quot;2026-10-24T07:56:12+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FMX9WJ9HVMLKQ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/MX9WJ9HVMLKQ/image.png" alt="image.png" height="575" width="1000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/MX9WJ9HVMLKQ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/MX9WJ9HVMLKQ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/MX9WJ9HVMLKQ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/MX9WJ9HVMLKQ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/MX9WJ9HVMLKQ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/MX9WJ9HVMLKQ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/MX9WJ9HVMLKQ/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Fig. 4. </strong>47-year-old man with hypertrophic cardiomyopathy due to MYBPC3 mutation (hematocrit level, 0.46 %).</p><p>(A) Short-axis view of late iodine enhancement (iodine map) with photon-counting CT.<br />
(B) Short-axis view of late gadolinium enhancement with cardiac MRI.<br />
(C-D) Extracellular volume polar maps (17-segment model of the American Heart Association) derived from C. Photon-counting CT and D. Cardiac MRI.    Eingefügter Text(20261024-07534…</p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Cardiac</p></td></tr><tr><td><p><strong>CCTA mode</strong></p></td><td><p>High-pitch or sequential, prospectively ECG-triggered depending on heart rate and rhythm</p></td></tr><tr><td><p><strong>tube voltage [kV]</strong></p></td><td><p>90</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>56</p></td></tr><tr><td><p><strong>reconstruction slice thickness [mm]</strong></p></td><td><p>0.4</p></td></tr><tr><td><p><strong> reconstruction increment [mm]</strong></p></td><td><p>0.4</p></td></tr><tr><td><p><strong>kernel</strong></p></td><td><p>Bv56</p></td></tr><tr><td><p><strong>iterative reconstruction</strong></p></td><td><p>QIR 4</p></td></tr><tr><td><p><strong>Late iodine enhancement mode</strong></p></td><td><p>High-pitch spectral acquisition</p></td></tr><tr><td><p><strong>Late iodine enhancement timing</strong></p></td><td><p>5 min after reinjection</p></td></tr><tr><td><p><strong>Late iodine enhancement tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>Late iodine enhancement IQ level</strong></p></td><td><p>100</p></td></tr><tr><td><p><strong>ECG gating / phase</strong></p></td><td><p>ECG-triggered, fixed absolute RR interval 280 ms</p></td></tr><tr><td><p><strong>VMI</strong></p></td><td><p>40 keV</p></td></tr><tr><td><p><strong>LIE reconstruction slice thickness [mm]</strong></p></td><td><p>2</p></td></tr><tr><td><p><strong>LIE reconstruction increment [mm]</strong></p></td><td><p>1</p></td></tr><tr><td><p><strong>LIE kernel</strong></p></td><td><p>Qr44</p></td></tr><tr><td><p><strong>LIE iterative reconstruction</strong></p></td><td><p>QIR 4</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>Iodine maps</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iobitridol 350 mg I/mL</p></td></tr><tr><td><p><strong>CCTA contrast volume</strong></p></td><td><p>50 mL</p></td></tr><tr><td><p><strong>LIE contrast volume</strong></p></td><td><p>Additional 50 mL</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>4–5 mL/s</p></td></tr><tr><td><p><strong>Saline flush</strong></p></td><td><p>20 mL</p></td></tr><tr><td><p><strong>Post-processing</strong></p></td><td><p>syngo.via VB40A; prototype Frontier Cardiac Functional Analyses for ECV</p></td></tr><tr><td><p><strong>Late-scan DLP [mGy·cm]</strong></p></td><td><p>106 ± 52</p></td></tr><tr><td><p><strong>Late-scan effective dose [mSv]</strong></p></td><td><p>1.47 ± 0.6</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>30 patients</strong>, 22 men; mean age ~59 years</p></td></tr><tr><td><p><strong>Global ECV</strong></p></td><td><p>PCCT <strong>30.0 ± 4.8%</strong> vs MRI <strong>30.62 ± 4.2%</strong>, <em>p</em> = 0.59</p></td></tr><tr><td><p><strong>PCCT–MRI agreement</strong></p></td><td><p>Bias <strong>0.6%</strong>, limits of agreement <strong>−1.49% to 2.75%</strong></p></td></tr><tr><td><p><strong>Segmental correlation</strong></p></td><td><p>Basal <strong>r = 0.89</strong>; mid-ventricular <strong>r = 0.85</strong>; apical <strong>r = 0.85</strong></p></td></tr><tr><td><p><strong>ECV threshold for LGE ≥15%</strong></p></td><td><p><strong>33.4%</strong>; sensitivity <strong>80%</strong>, specificity <strong>76%</strong>, AUC <strong>0.77</strong></p></td></tr><tr><td><p><strong>Clinical correlations</strong></p></td><td><p>Peak VO₂ <strong>r = −0.76</strong>; NT-proBNP <strong>r = 0.59</strong></p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Gkizas C, Longere B, Bechrouri S, Ridon H, Rodriguez Musso A, Haidar M, Croisille C, Montaigne D, De Groote P, Pontana F. <em>Photon-counting CT myocardial extracellular volume: A non-invasive biomarker for fibrosis in patients with hypertrophic cardiomyopathy.</em> <strong>Diagnostic and Interventional Imaging.</strong> 2026;107(1):17–24. doi:10.1016/j.diii.2025.09.001. </p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Huijberts | Visualisation of lenticulostriate arteries using PCCT</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/589/2026-huijberts-visualisation-of-lenticulostriate-arteries-using-pcct</link>
        <pubDate>Wed, 21 Oct 2026 11:44:48 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">589@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In this retrospective cohort of <strong>159 patients with subarachnoid haemorrhage</strong>, UHR PCCT substantially improved lenticulostriate artery (LSA) visualization compared with conventional EID-CTA. For branches arising <strong>&gt;5 mm from the MCA origin</strong>, PCCT detection approached DSA—for example, <strong>93% vs 85%</strong> for observer 1 in the left hemisphere (<em>p</em> = 0.62)—while EID-CTA detected only <strong>49%</strong> in the unpaired comparison.</p><p></p><p>PCCT remained inferior to DSA for depicting the <strong>full distal extent</strong> of larger LSA branches. Median LSA length &gt;5 mm from the MCA origin was <strong>23 mm on PCCT vs 40 mm on DSA</strong> for observer 1, whereas PCCT nevertheless showed significantly longer measurable branches than EID-CTA (<strong>23 vs 15 mm</strong>, <em>p</em> &lt; 0.001).</p><p></p><p>The main technical trade-off was dose: the optimized <strong>90-kVp, 0.2-mm UHR PCCT protocol</strong> achieved markedly better small-vessel visualization, but CTDIvol ranged <strong>17–27 mGy</strong>, above the reported EID-CTA ranges. Thus, PCCT appears promising as a <strong>non-invasive alternative for LSA assessment</strong>, but DSA remains superior for the most distal branches and prospective clinical validation is needed.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.ejradiology.com%2Farticle%2FS0720-048X%2825%2900704-1%2Ffulltext" rel="nofollow noopener ugc" role="button">Access publication</a></p><p><strong>SUPPLEMENTAL APPENDIX</strong></p><div data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/VKY9D5W3ZCND\/1-s2-0-s0720048x25007041-mmc1.pdf&quot;,&quot;name&quot;:&quot;1-s2.0-S0720048X25007041-mmc1.pdf&quot;,&quot;type&quot;:&quot;application\/pdf&quot;,&quot;size&quot;:1678327,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FVKY9D5W3ZCND%2F1-s2-0-s0720048x25007041-mmc1.pdf&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1931,&quot;dateInserted&quot;:&quot;2026-10-21T11:50:02+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;file&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <a rel="nofollow" href="https://connect.siemens-healthineers.com/api/v2/media/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FVKY9D5W3ZCND%2F1-s2-0-s0720048x25007041-mmc1.pdf" download="" aria-label="1-s2.0-S0720048X25007041-mmc1.pdf">
        1-s2.0-S0720048X25007041-mmc1.pdf
    </a>
</div>
<span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/IT3I402TLMCB\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1432412,&quot;width&quot;:2000,&quot;height&quot;:1175,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FIT3I402TLMCB%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1929,&quot;dateInserted&quot;:&quot;2026-10-21T11:42:51+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FIT3I402TLMCB%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/IT3I402TLMCB/image.png" alt="image.png" height="1175" width="2000" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/IT3I402TLMCB/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/IT3I402TLMCB/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/IT3I402TLMCB/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/IT3I402TLMCB/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/IT3I402TLMCB/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/IT3I402TLMCB/image.png 2000w, https://us.v-cdn.net/6038601/uploads/IT3I402TLMCB/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2. </strong>LSA visualisation on DSA, EID-CTA and PCD-CT Note: (A) Rotational angiography; (B) Conventional anterior-to-posterior imaging; (C) 3D angiography cone beam CT (D) Second-generation dual source EID-CTA [flash]; (E) Third-generation dual source EID-CTA [force]; (F) PCD-CT.</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/NP8VB0OIXAE7\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:195701,&quot;width&quot;:761,&quot;height&quot;:829,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FNP8VB0OIXAE7%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1932,&quot;dateInserted&quot;:&quot;2026-10-21T12:28:01+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FNP8VB0OIXAE7%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/NP8VB0OIXAE7/image.png" alt="image.png" height="829" width="761" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/NP8VB0OIXAE7/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/NP8VB0OIXAE7/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/NP8VB0OIXAE7/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/NP8VB0OIXAE7/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/NP8VB0OIXAE7/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/NP8VB0OIXAE7/image.png 2000w, https://us.v-cdn.net/6038601/uploads/NP8VB0OIXAE7/image.png" sizes="100vw" /></a>
    </span>
</span>
<p>Table S1: Detailed information on employed CTA imaging protocols</p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Intracranial CTA / lenticulostriate arteries</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>UHR</p></td></tr><tr><td><p><strong>Tube voltage [kVp]</strong></p></td><td><p>90</p></td></tr><tr><td><p><strong>Tube current-time product [mAs]</strong></p></td><td><p>250–330</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>17–27</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.4</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>120 × 0.2 mm</p></td></tr><tr><td><p><strong>Reconstruction slice thickness [mm]</strong></p></td><td><p>0.2</p></td></tr><tr><td><p><strong>Kernels</strong></p></td><td><p>Hv40, Hv72, Bv40</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>Polychromatic T3D</p></td></tr><tr><td><p><strong>Image analysis</strong></p></td><td><p>Coronal MIP with reader-adjustable slab thickness, angulation, and window/level</p></td></tr><tr><td><p><strong>LSA assessment</strong></p></td><td><p>Presence, number, length, and subjective image quality</p></td></tr><tr><td><p><strong>Reference standard</strong></p></td><td><p>DSA, including rotational angiography, AP angiography, and/or 3D cone-beam angiography</p></td></tr></table></div><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>159 patients</strong></p></td></tr><tr><td><p><strong>PCCT vs DSA detection, LSA &gt;5 mm</strong></p></td><td><p>Observer 1: <strong>93% vs 85%</strong>, <em>p</em> = 0.62; Observer 2: <strong>78% vs 78%</strong>, <em>p</em> = 1.00</p></td></tr><tr><td><p><strong>PCCT vs EID-CTA detection, LSA &gt;5 mm</strong></p></td><td><p>Observer 1: <strong>93% vs 49%</strong>, <em>p</em> &lt; 0.001; Observer 2: <strong>79% vs 55%</strong>, <em>p</em> = 0.03</p></td></tr><tr><td><p><strong>LSA length &gt;5 mm, PCCT vs DSA</strong></p></td><td><p>Observer 1: <strong>23 [21–29] vs 40 [34–49] mm</strong>, <em>p</em> &lt; 0.001</p></td></tr><tr><td><p><strong>LSA length &gt;5 mm, PCCT vs EID-CTA</strong></p></td><td><p>Observer 1: <strong>23 [19–28] vs 15 [9–22] mm</strong>, <em>p</em> &lt; 0.001</p></td></tr><tr><td><p><strong>Inter-reader reliability</strong></p></td><td><p>Generally poor-to-moderate; PCCT left-hemisphere length ICC <strong>0.610</strong></p></td></tr></table></div><p><strong>Source:</strong><br />
Huijberts I, Wagemans BAJM, Pinckaers FME, Robbe MMQ, van Zwam WH, van Oostenbrugge RJ, Postma AA. <em>Visualisation of lenticulostriate arteries using photon counting detector CT angiography: A retrospective cohort study.</em> <strong>European Journal of Radiology.</strong> 2026;195:112618. doi:10.1016/j.ejrad.2025.112618.</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Hellms | Non-gated pediatric cardiac PCCT cuts dose while preserving image quality</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/562/2026-hellms-non-gated-pediatric-cardiac-pcct-cuts-dose-while-preserving-image-quality</link>
        <pubDate>Mon, 19 Oct 2026 04:00:53 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">562@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In 37 children with congenital heart disease matched to 37 EID-CT controls by water-equivalent diameter, <strong>non-ECG-gated high-pitch PCCT substantially reduced radiation exposure</strong>: CTDIvol 0.20 ± 0.12 vs 0.37 ± 0.17 mGy and DLP 4.06 ± 3.22 vs 7.21 ± 4.67 mGy·cm (p &lt; 0.001 for both), corresponding to roughly 46% and 44% reductions, respectively.</p><p></p><p>Despite the lower dose, SNR, CNR, beam-hardening artifacts, overall subjective image quality, and proximal coronary-artery visualization were not significantly different between PCCT and EID-CT.<strong> This was achieved with an extremely fast 70-kV, pitch-3.2, non-ECG-gated PCCT acquisition</strong>. </p><p></p><p>The practical implication is particularly relevant for infants and young children requiring repeated cardiovascular imaging: sub-second, free-breathing cardiac PCCT can <strong>preserve diagnostic anatomy without ECG gating at very low radiation dose</strong>. However, patients with visible metallic devices were excluded, and the retrospective cohort was relatively small.  </p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00330-025-11719-6" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/LWX6KP8C9WWQ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:929412,&quot;width&quot;:2000,&quot;height&quot;:1150,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FLWX6KP8C9WWQ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1868,&quot;dateInserted&quot;:&quot;2026-10-15T16:18:27+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FLWX6KP8C9WWQ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/LWX6KP8C9WWQ/image.png" alt="image.png" height="1150" width="2000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/LWX6KP8C9WWQ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/LWX6KP8C9WWQ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/LWX6KP8C9WWQ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/LWX6KP8C9WWQ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/LWX6KP8C9WWQ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/LWX6KP8C9WWQ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/LWX6KP8C9WWQ/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 4. </strong>A, B Cardiac examination on photon-counting detector CT of a 7-month-old female patient, born with tetralogy of Fallot. Volume CT dose index (CTDIvol) of this examination was 0.11 mGy, dose length product (DLP) was 1.9 mGy<em>cm, water-equivalent diameter was 118 mm. C, D Cardiac examination on energy-integrating detector CT of a 5-month-old female patient, born with atrioventricular septal defect. CTDIvol of this examination was 0.35 mGy, DLP was 5.8 mGy</em>cm, water-equivalent diameter was 118 mm. The cardiac anatomy can be very well depicted in both studies, including the coronary arteries (arrows in the axial orientations A and C). B and D show the aortic arch in parasagittal orientation.</p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>PCCT</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Whole thorax and heart</p></td></tr><tr><td><p><strong>Patient position</strong></p></td><td><p>Supine, arms elevated</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Craniocaudal</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>Quantum Fast high-pitch helical</p></td></tr><tr><td><p><strong>ECG gating</strong></p></td><td><p>None</p></td></tr><tr><td><p><strong>Breathing</strong></p></td><td><p>Free-breathing</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p><strong>70</strong></p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p><strong>45</strong></p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>Automated exposure control</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p><strong>0.20 ± 0.12</strong></p></td></tr><tr><td><p><strong>DLP [mGy·cm]</strong></p></td><td><p><strong>4.06 ± 3.22</strong></p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p><strong>0.25</strong></p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p><strong>3.2</strong></p></td></tr><tr><td><p><strong>Detector slice collimation [mm]</strong></p></td><td><p><strong>144 × 0.4</strong></p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p><strong>768 × 768</strong></p></td></tr><tr><td><p><strong>Reconstruction slice thickness [mm]</strong></p></td><td><p><strong>1.0</strong></p></td></tr><tr><td><p><strong>Reconstruction increment [mm]</strong></p></td><td><p><strong>0.7</strong></p></td></tr><tr><td><p><strong>Kernel</strong></p></td><td><p><strong>Br40</strong></p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p><strong>QIR 2</strong></p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iomeprol 400</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p><strong>7 mL</strong> at 3–6 kg; <strong>1 mL/kg</strong> at ≥7 kg</p></td></tr><tr><td><p><strong>Saline</strong></p></td><td><p>Saline flush</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>Bolus tracking; scan initiated when all four cardiac chambers were optimally opacified</p></td></tr><tr><td><p><strong>Acquisition time</strong></p></td><td><p>&lt;1 s on average</p></td></tr></table></div><p>The study used a CARE keV <strong>Image Quality level of 45</strong> as the PCCT reference-mAs control parameter. Acquisition was performed without ECG triggering, using free-breathing high-pitch scanning. </p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>PCCT vs EID-CT</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>37 vs 37</strong> size-matched children</p></td></tr><tr><td><p><strong>CTDIvol</strong></p></td><td><p><strong>0.20 ± 0.12 vs 0.37 ± 0.17 mGy</strong>, <em>p</em> &lt; 0.001</p></td></tr><tr><td><p><strong>DLP</strong></p></td><td><p><strong>4.06 ± 3.22 vs 7.21 ± 4.67 mGy·cm</strong>, <em>p</em> &lt; 0.001</p></td></tr><tr><td><p><strong>Dose reduction</strong></p></td><td><p>Approximately <strong>46% lower CTDIvol</strong> and <strong>44% lower DLP</strong></p></td></tr><tr><td><p><strong>Quantitative image quality</strong></p></td><td><p>No significant difference in <strong>SNR, CNR, or beam-hardening artifacts</strong></p></td></tr><tr><td><p><strong>Qualitative image quality</strong></p></td><td><p>No significant difference in overall image quality or proximal coronary visualization</p></td></tr></table></div><p><strong>Source:</strong><br />
Hellms S, Werncke T, Böttcher J, Happel CM, Eckstein J, Krueger MB, Panknin C, Pfeil A, Kaireit TF, Beerbaum P, Vogel-Claussen J, Wacker F, Renz DM. <em>Reduction of radiation exposure and preserved image quality using photon-counting detector cardiac computed tomography without electrocardiographic gating in children with congenital heart disease.</em> <strong>European Radiology.</strong> 2026;36:324–333. doi:10.1007/s00330-025-11719-6.</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Volovici | UHR PCCT pure-lumen imaging for neurosurgical navigation</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/552/2026-volovici-uhr-pcct-pure-lumen-imaging-for-neurosurgical-navigation</link>
        <pubDate>Sun, 11 Oct 2026 09:35:12 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">552@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In this selected pilot cohort of 20 complex neurosurgical cases, UHR PCCT provided additional anatomical information beyond conventional MRI/CT, particularly for arterial anatomy (11/20, 55%), tumor vascular supply (7/20, 35%), venous anatomy (6/20, 30%), and skull-base/orbital/osseous involvement (8/20, 40%). The greatest apparent benefit was in complex skull-base meningiomas and vascular lesions.</p><p></p><p>The technical advantage was the combination of 0.2-mm-class UHR vascular imaging, bone-subtracted pure-lumen reconstructions, spectral imaging, and simultaneous osseous depiction. This allowed visualization of small-caliber vessels, tumor feeders, perforators, venous drainage, vessel encasement/displacement, and hyperostotic or transosseous tumor extension relevant to surgical navigation.</p><p></p><p>These results are explicitly hypothesis-generating rather than evidence of clinical superiority. The cohort was strongly selected—19 of 45 PCCT examinations were excluded because they showed no additional findings—and comparisons were unblinded and not validated systematically against operative or angiographic reference standards. The proposed role is therefore PCCT complementary to MRI, rather than replacing MRI for lesion characterization. </p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS2772529426015274" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/7OUOQ9SKWYHK\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:612391,&quot;width&quot;:691,&quot;height&quot;:532,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7OUOQ9SKWYHK%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1845,&quot;dateInserted&quot;:&quot;2026-10-11T09:29:30+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7OUOQ9SKWYHK%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/7OUOQ9SKWYHK/image.png" alt="image.png" height="532" width="691" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/7OUOQ9SKWYHK/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/7OUOQ9SKWYHK/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/7OUOQ9SKWYHK/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/7OUOQ9SKWYHK/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/7OUOQ9SKWYHK/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/7OUOQ9SKWYHK/image.png 2000w, https://us.v-cdn.net/6038601/uploads/7OUOQ9SKWYHK/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Fig. 3. </strong>Case #8. Spheno-orbital meningioma. Coronal T1w post-contrast MRI (A), post-contrast CT (B), and pure-lumen reconstruction (C) delineate the lesion, demonstrating clearer differentiation between tumor parenchyma and vascular structures. Sagittal MIP CTA (D) shows extensive intratumoral radial vascularity and underlying hyperostosis (*). 3D reconstructions show tumor vascularization (E) and a hypertrophic middle meningeal artery (F: arrow).</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/7BEAVENBTISO\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:654311,&quot;width&quot;:1000,&quot;height&quot;:575,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7BEAVENBTISO%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1847,&quot;dateInserted&quot;:&quot;2026-10-11T09:31:30+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F7BEAVENBTISO%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/7BEAVENBTISO/image.png" alt="image.png" height="575" width="1000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/7BEAVENBTISO/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/7BEAVENBTISO/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/7BEAVENBTISO/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/7BEAVENBTISO/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/7BEAVENBTISO/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/7BEAVENBTISO/image.png 2000w, https://us.v-cdn.net/6038601/uploads/7BEAVENBTISO/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 4. </strong>Case #13. Left fronto-parietal (precentral gyrus) AVM with a large (&gt;4 cm) nidus. DSA (A) demonstrates the AVM nidus with arterial supply from the left ACA and MCA, and superficial venous drainage without deep venous outflow. A 3D reconstruction of contrast-enhanced PCCT (B) depicts the AVM in relation to the surrounding vasculature. Coronal 0.2 mm PCCT reconstruction (C) provides high-resolution and highly detailed delineation of the nidus and adjacent vessels, while a matched 1.6 mm post-contrast MRI reconstruction (D) through the same plane provides cross-modality correlation.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Intracranial / preoperative neuronavigation</p></td></tr><tr><td><p><strong>Acquisition</strong></p></td><td><p>UHR PCCT angiography ± venography</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>Helical, single-tube acquisition</p></td></tr><tr><td><p><strong>Tube voltage</strong></p></td><td><p>120 kV</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>90–145</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>Automatic tube-current modulation, CARE Dose4D</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>18.2 mean</p></td></tr><tr><td><p><strong>DLP [mGy·cm]</strong></p></td><td><p>352 mean</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>0.55–0.80</p></td></tr><tr><td><p><strong>Detector collimation</strong></p></td><td><p>0.2 mm (total collimation 24 mm)</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>0.2–0.4 mm</p></td></tr><tr><td><p><strong>Kernels</strong></p></td><td><p>Hv, Hr, Qr (high)</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>Q3–Q4</p></td></tr><tr><td><p><strong>VMI</strong></p></td><td><p>Low-noise/UHR series at 55 keV; spectral display primarily at 40 keV</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>Bone-subtracted angiographic pure-lumen images</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iodixanol 320 mg I/mL</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>80 mL</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>5.0 mL/s</p></td></tr><tr><td><p><strong>Saline flush</strong></p></td><td><p>40 mL</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>Bolus tracking</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study cohort</strong></p></td><td><p><strong>20 selected cases</strong> from 45 preoperative UHR PCCT examinations; <strong>12/20 meningiomas</strong></p></td></tr><tr><td><p><strong>Additional arterial information</strong></p></td><td><p><strong>11/20 (55%)</strong>, including perforators in <strong>2/20 (10%)</strong></p></td></tr><tr><td><p><strong>Additional tumor vascular supply</strong></p></td><td><p><strong>7/20 (35%)</strong></p></td></tr><tr><td><p><strong>Additional venous information</strong></p></td><td><p><strong>6/20 (30%)</strong></p></td></tr><tr><td><p><strong>Additional skull-base/orbital/osseous information</strong></p></td><td><p><strong>8/20 (40%)</strong></p></td></tr><tr><td><p><strong>Radiation dose</strong></p></td><td><p>PCCT CTA: <strong>CTDIvol 18.2 mGy, DLP 352 mGy·cm</strong> vs institutional standard neuronavigation CT: <strong>50.6 mGy, 1046 mGy·cm</strong></p></td></tr></table></div><p><strong></strong></p><p><strong>Source:</strong><br />
Volovici V, Sadigh Y, Dijkshoorn M, van der Eerden A, Gahrmann R, et al. <em>Pre-operative visualization of cerebral vasculature using photon-counting CT ultra-high resolution pure lumen imaging.</em> <strong>Brain and Spine.</strong> 2026;107451. doi:10.1016/j.bas.2026.107451. </p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Nishii | Optimization of the kernel for temporal bone imaging in PCCT</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/553/2026-nishii-optimization-of-the-kernel-for-temporal-bone-imaging-in-pcct</link>
        <pubDate>Mon, 12 Oct 2026 10:00:12 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">553@/en/discussions</guid>
        <description><![CDATA[<div><div><p>This study combined physical phantom testing of 11 UHR reconstruction kernels (Hr60–Hr98) with clinical visual assessment in 12 patients / 24 temporal bones. Physically, increasing kernel sharpness improved spatial resolution but increased high-frequency noise: Hr96 achieved the highest measured resolution, whereas Hr60 produced the lowest noise.</p><p></p><p>The objective system-performance analysis favored Hr72 as the best resolution–noise compromise. However, expert visual assessment of Hr60, Hr72, Hr76, and Hr84 consistently favored Hr76, particularly for visualization of the cochlea and fine middle-ear anatomy; Hr60 performed worst despite its low noise.</p><p></p><p>The practical message is that maximum sharpness is not equivalent to maximum diagnostic image quality. For UHR temporal-bone PCCT at 0.2-mm reconstruction, Hr76 appears to provide the most useful clinical balance, while Hr72 remains a reasonable slightly smoother alternative.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1078817425004183" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/1KE708GL0E0K\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:400007,&quot;width&quot;:1000,&quot;height&quot;:575,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F1KE708GL0E0K%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1848,&quot;dateInserted&quot;:&quot;2026-10-11T09:39:02+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F1KE708GL0E0K%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/1KE708GL0E0K/image.png" alt="image.png" height="575" width="1000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/1KE708GL0E0K/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/1KE708GL0E0K/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/1KE708GL0E0K/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/1KE708GL0E0K/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/1KE708GL0E0K/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/1KE708GL0E0K/image.png 2000w, https://us.v-cdn.net/6038601/uploads/1KE708GL0E0K/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 5. </strong>Typical CT images used to evaluate the incudomalleolar joint. (a), (b), (c), and (d) correspond to the images reconstructed using Hr60, Hr72, Hr76, and Hr84, respectively. Sharper kernels enhanced the visualization of fine structures.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Temporal bone</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Quantum HD (UHR)</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>Effective mAs</strong></p></td><td><p>Phantom: 305; </p><p>clinical cohort: 266.1 ± 18.1</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>Clinical cohort: 280</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>Automatic exposure control</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>Phantom: ~52; </p><p>clinical cohort: 45.63 ± 3.11</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>Phantom: 0.50</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>Phantom: 0.55</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>120 × 0.2 mm</p></td></tr><tr><td><p><strong>FOV [mm]</strong></p></td><td><p>Phantom: 100 × 100</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>Slice thickness</strong></p></td><td><p>0.2 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>0.2 mm</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 1 (to preserve high-frequency information)</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>T3D polychromatic images</p></td></tr><tr><td><p><strong>Kernels physically tested</strong></p></td><td><p>Hr60, Hr64, Hr68, Hr72, Hr76, Hr80, Hr84, Hr89, Hr92, Hr96, Hr98</p></td></tr><tr><td><p><strong>Kernels visually tested</strong></p></td><td><p>Hr60, Hr72, Hr76, Hr84</p></td></tr><tr><td><p><strong>Clinical evaluation structures</strong></p></td><td><p>Stapes footplate, cochlea, incudomalleolar joint, overall image quality</p></td></tr><tr><td><p><strong>Clinical image review</strong></p></td><td><p>24 bilateral temporal-bone image sets; 2 radiologists</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Highest spatial resolution</strong></p></td><td><p><strong>Hr96</strong>, 10% TTF <strong>2.712 cycles/mm</strong></p></td></tr><tr><td><p><strong>Lowest image noise</strong></p></td><td><p><strong>Hr60</strong></p></td></tr><tr><td><p><strong>Best physical resolution–noise balance</strong></p></td><td><p><strong>Hr72</strong>, highest SPF</p></td></tr><tr><td><p><strong>Best visually rated kernel</strong></p></td><td><p><strong>Hr76</strong> overall</p></td></tr><tr><td><p><strong>Cochlea ranking</strong></p></td><td><p>Hr76 ranked highest; significantly better than Hr84</p></td></tr><tr><td><p><strong>Inter-reader agreement</strong></p></td><td><p>ρ <strong>0.634–0.733</strong> for ranking and <strong>0.834–0.939</strong> for Likert ratings</p></td></tr></table></div><p><strong>Source:</strong><br />
Nishii S, Asahara T, Morimitsu Y, Kajisaki S, Akagi N, Honda M, Hayashi H, Sugaya A, Munetomo K, Higaki F, Hiraki T, Iguchi T. <em>Optimization of the reconstruction kernel for temporal bone imaging using photon-counting detector CT: A combined physical and visual evaluation.</em> <strong>Radiography.</strong> 2026;32(2):103274. doi:10.1016/j.radi.2025.103274.</p>]]>
        </description>
    </item>
    <item>
        <title>PCCT for coronary assessment and functional imaging in Takotsubo cardiomyopathy</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/511/pcct-for-coronary-assessment-and-functional-imaging-in-takotsubo-cardiomyopathy</link>
        <pubDate>Thu, 01 Oct 2026 10:02:30 +0000</pubDate>
        <category>Case reports</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">511@/en/discussions</guid>
        <description><![CDATA[<h3 data-id="balint-szilveszter-borbala-vattay-peter-csongor-milan-vecsey-nagy"><a data-username="Bálint Szilveszter" data-userid="159" rel="nofollow" href="https://connect.siemens-healthineers.com/en/profile/159/B%C3%A1lint%20Szilveszter">@Bálint Szilveszter</a>, Borbála Vattay, Péter Csongor,  <a data-username="Milan Vecsey-Nagy" data-userid="755" rel="nofollow" href="https://connect.siemens-healthineers.com/en/profile/755/Milan%20Vecsey-Nagy">@Milan Vecsey-Nagy</a><br /></h3><h4 data-id="varosmajor-heart-and-vascular-centre-cardiac-ct-working-group-budapest-hungary">Városmajor Heart and Vascular Centre, Cardiac CT Working Group, Budapest, Hungary</h4><h4 data-id="september-29-2026">September 29, 2026</h4><p></p><div data-embedjson="{&quot;height&quot;:&quot;360&quot;,&quot;width&quot;:&quot;640&quot;,&quot;isKnowledge&quot;:false,&quot;url&quot;:&quot;https:\/\/siemens-healthineers.bynder.com\/asset\/a85e1bdc-bf2b-4a4d-94a0-dc890f0a7651\/CT-NAEOTOM-CONNECT-CaseReport-Takutsobu-2-VIDEO-2026.mp4&quot;,&quot;embedType&quot;:&quot;iframe&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fsiemens-healthineers.bynder.com%2Fasset%2Fa85e1bdc-bf2b-4a4d-94a0-dc890f0a7651%2FCT-NAEOTOM-CONNECT-CaseReport-Takutsobu-2-VIDEO-2026.mp4" rel="nofollow noopener ugc">
        https://siemens-healthineers.bynder.com/asset/a85e1bdc-bf2b-4a4d-94a0-dc890f0a7651/CT-NAEOTOM-CONNECT-CaseReport-Takutsobu-2-VIDEO-2026.mp4
    </a>
</div><div data-embedjson="{&quot;height&quot;:&quot;360&quot;,&quot;width&quot;:&quot;640&quot;,&quot;isKnowledge&quot;:false,&quot;url&quot;:&quot;https:\/\/siemens-healthineers.bynder.com\/asset\/377c2032-a4c9-4561-9e4f-d6479c6dbd1d\/CT-NAEOTOM-CONNECT-CaseReport-Takutsobu-1-VIDEO-2026.mp4&quot;,&quot;embedType&quot;:&quot;iframe&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fsiemens-healthineers.bynder.com%2Fasset%2F377c2032-a4c9-4561-9e4f-d6479c6dbd1d%2FCT-NAEOTOM-CONNECT-CaseReport-Takutsobu-1-VIDEO-2026.mp4" rel="nofollow noopener ugc">
        https://siemens-healthineers.bynder.com/asset/377c2032-a4c9-4561-9e4f-d6479c6dbd1d/CT-NAEOTOM-CONNECT-CaseReport-Takutsobu-1-VIDEO-2026.mp4
    </a>
</div><p></p><h2 data-id="history">History</h2><h4 data-id="why-did-the-patient-come-for-a-ct-exam">Why did the patient come for a CT exam?</h4><p>A 63-year-old female patient, presenting with typical chest pain, was referred for coronary imaging to clarify her coronary status and exclude acute coronary syndrome.</p><p>Laboratory tests showed marked myocardial injury and neurohormonal activation, with highly elevated high-sensitivity troponin I of 2032 ng/L, CK of 565 U/L, CK-MB of 43 U/L, and NT-proBNP of 1589.7 pg/mL.</p><p>Mild inflammatory activity was also present, with leukocytosis of 12.86 G/L, neutrophilia, and mildly elevated CRP of 6.2 mg/L. Renal function was preserved, with an eGFR of 107 mL/min.</p><p>An initial transthoracic echocardiography showed mildly to moderately reduced global left ventricular systolic function, with a left ventricular ejection fraction of 42% by Simpson’s method. Regional wall motion abnormalities were present, with hypokinesis of the midventricular segments and near akinesia of the apical third of the left ventricle. Mild mitral regurgitation and moderate tricuspid regurgitation were present.</p><p>Right ventricular size was normal, and right ventricular longitudinal systolic function was preserved. The estimated pulmonary artery systolic pressure was mildly elevated.</p><p>Coronary CT angiography (CCTA) was recommended to exclude obstructive coronary artery disease.</p><p></p><h2 data-id="diagnosis">Diagnosis</h2><h4 data-id="what-were-the-ct-findings-and-what-happened-to-the-patient-after-ct">What were the CT findings, and what happened to the patient after CT?</h4><p>Coronary CT angiography was performed using a dual-source photoncounting detector CT scanner (Siemens NAEOTOM Alpha Peak).</p><p>The estimated CCTA radiation dose was 397 mGy·cm. Iomeron 400 was administered with a contrast volume of 90 mL and a flow of 5.5 ml/s. The patient received 0.8 mg sublingual nitroglycerin prior to the examination. Heart rate during the scan was 93–97/min with sinus rhythm.</p><p>The coronary calcium score was 4.</p><p>The patient had a left-dominant coronary artery system and normal origin and course of the coronary arteries. No relevant coronary atherosclerosis or luminal stenosis were detected. Only minimal vessel wall irregularities were observed, with small specks of calcified plaque in the distal left anterior descending (LAD) artery (Figure 1. and 2.)</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/F7ZVE7HEDSFS\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:1518105,&quot;width&quot;:2000,&quot;height&quot;:1150,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FF7ZVE7HEDSFS%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1716,&quot;dateInserted&quot;:&quot;2026-09-03T08:50:20+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FF7ZVE7HEDSFS%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/F7ZVE7HEDSFS/image.png" alt="image.png" height="1150" width="2000" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/F7ZVE7HEDSFS/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/F7ZVE7HEDSFS/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/F7ZVE7HEDSFS/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/F7ZVE7HEDSFS/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/F7ZVE7HEDSFS/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/F7ZVE7HEDSFS/image.png 2000w, https://us.v-cdn.net/6038601/uploads/F7ZVE7HEDSFS/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1.</strong> CT coronary angiography demonstrating<br />&#13; normal coronary artery anatomy with no<br />&#13; evidence of a significant stenosis.</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/20KUJCL6DHDD\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:40075,&quot;width&quot;:526,&quot;height&quot;:219,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F20KUJCL6DHDD%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1714,&quot;dateInserted&quot;:&quot;2026-09-03T08:34:15+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F20KUJCL6DHDD%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/20KUJCL6DHDD/image.png" alt="image.png" height="219" width="526" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/20KUJCL6DHDD/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/20KUJCL6DHDD/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/20KUJCL6DHDD/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/20KUJCL6DHDD/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/20KUJCL6DHDD/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/20KUJCL6DHDD/image.png 2000w, https://us.v-cdn.net/6038601/uploads/20KUJCL6DHDD/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2.</strong> Electrocardiogram (ECG) during Prospective<br />&#13; Sequential Cardiac CT Acquisition.</p><p></p><p>Coronary CT angiography was performed using a prospectively ECG-triggered sequential axial acquisition. Given the patient’s heart rate, exceeding 90 beats/min, multiphase image reconstruction was performed to ensure optimal image quality and to allow simultaneous assessment of coronary anatomy and left ventricular function.</p><p>In addition to coronary artery evaluation, the multiphase datasets were analyzed for regional wall-motion abnormalities and cardiac chamber volumetry.</p><p>Coronary analysis demonstrated non-obstructive coronary artery disease, with only minimal calcified plaque in the distal left anterior descending artery. Functional assessment revealed severe apical hypokinesis/akinesis with associated midventricular dyskinesis and preserved basal contractility, resulting in the characteristic apical ballooning pattern of a classical Takotsubo syndrome (Figure 3).</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/BZXXKYQSKXYQ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:169153,&quot;width&quot;:964,&quot;height&quot;:360,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FBZXXKYQSKXYQ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1715,&quot;dateInserted&quot;:&quot;2026-09-03T08:34:58+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FBZXXKYQSKXYQ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/BZXXKYQSKXYQ/image.png" alt="image.png" height="360" width="964" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/BZXXKYQSKXYQ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/BZXXKYQSKXYQ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/BZXXKYQSKXYQ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/BZXXKYQSKXYQ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/BZXXKYQSKXYQ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/BZXXKYQSKXYQ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/BZXXKYQSKXYQ/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3. </strong>Left Ventricular Apical Dysfunction Consistent with Takotsubo Pattern on Multiphase Cardiac CT Functional<br />&#13; Analysis. Multiphase cardiac CT-derived left ventricular wall-motion bull’s-eye map demonstrating a regional<br />&#13; gradient of myocardial contractility with preserved basal function (red–yellow), reduced mid-ventricular motion,<br />&#13; and markedly impaired apical wall motion (blue–purple). The pattern shows an apical-dominant distribution of<br />&#13; dysfunction, consistent with a classical Takotsubo-type contraction abnormality in the appropriate clinical context<br />&#13; (left). Mildly increased left ventricular end-diastolic and end-systolic volume indices (indexed to body surface area)<br />&#13; were detected, with mildly reduced systolic function (LVEF 45%) based on the available cardiac phases.</p><p>Mildly increased left ventricular end-diastolic and end-systolic volume indices were detected, with mildly reduced systolic function (LVEF 45%).</p><p>As an incidental extracardiac finding, scattered bilateral ground-glass opacities with patchy consolidations were detected, most consistent with bronchopneumonia given the elevated inflammatory laboratory markers.</p><p></p><h2 data-id="comments">Comments</h2><h4 data-id="is-there-any-clinically-interesting-aspect-of-the-case-to-discuss-what-difference-did-photon-counting-ct-make-for-the-patient">Is there any clinically interesting aspect of the case to discuss? <br />
What difference did photon-counting CT make for the patient?</h4><p>This case highlights the clinical value of the photon-counting coronary CT angiography in the diagnostic work-up of patients presenting with acute chest pain, elevated cardiac biomarkers, and electrocardiographic changes suggestive of acute coronary syndrome.</p><p>Beyond excluding obstructive coronary artery disease, CT angiography enables comprehensive myocardial functional assessment, allowing identification of the characteristic apical ballooning pattern consistent with Takotsubo syndrome, thereby supporting a working diagnosis of MINOCA – now defined as myocardial injury with non-obstructive coronary arteries (Fifth Universal Definition of Myocardial Infarction, 2026) – with Takotsubo syndrome as the most likely final diagnosis.</p><p>The ability of photon-counting CT to simultaneously evaluate coronary anatomy, plaque burden, and left ventricular function in a single examination may facilitate rapid differentiation between obstructive coronary disease and alternative causes of acute myocardial injury, potentially reducing the need for additional imaging or invasive angiography in selected patients.</p><p>This case also demonstrates the technical advantages of photoncounting coronary CT angiography for combined coronary and functional cardiac assessment in an acute setting.</p><p>The system provides excellent spatial and temporal resolution, enabling high-quality coronary plaque evaluation, even at elevated heart rates (&gt;90 beats/min), with minimal motion artefact. This allows for a reliable assessment of the coronary lumen and detection of only minimal calcified plaque in the distal LAD.</p><p>In addition, multiphase ECG-gated reconstructions offer excellent temporal resolution for detailed motion analysis of all cardiac chambers, permitting accurate depiction of regional wall-motion abnormalities.</p><p>Overall, the combination of high spatial fidelity for plaque characterization and high temporal resolution for functional assessment underscores the robustness of photon-counting CT for integrated “one-stop” coronary and myocardial evaluation, even under challenging heart rate conditions.</p><p>Note that the role of CT in this case should be interpreted within its limits. CCTA was requested to rule out obstructive coronary artery disease in a haemodynamically stable patient; because of the elevated heart rate, a multiphase acquisition was used, which additionally depicted the wall-motion pattern. CCTA can therefore exclude obstructive coronary artery disease and further reinforce echocardiographic findings suggestive of Takotsubo syndrome, but it does not establish the diagnosis on its own. Current recommendations advise cardiac magnetic resonance imaging when the final diagnosis remains uncertain—particularly in the presence of inflammatory red flags—and follow-up echocardiography to document recovery of left ventricular function. In our patient, who was referred to our centre for CT only, further diagnostic work-up and follow-up were performed at the referring institution.</p><p></p><h2 data-id="examination-protocol">Examination Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><td><p><strong>Scanner</strong></p></td><td><p><strong>NAEOTOM Alpha.Peak</strong></p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Heart</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>QuantumPlus</p></td></tr><tr><td><p><strong>Scan length</strong></p></td><td><p>126 mm</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Cranio-caudal</p></td></tr><tr><td><p><strong>Scan time</strong></p></td><td><p>2,38 s</p></td></tr><tr><td><p><strong>Tube voltage</strong></p></td><td><p>140 kV</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>65</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>CTDIvol</strong></p></td><td><p>31.5 mGy</p></td></tr><tr><td><p><strong>DLP</strong></p></td><td><p>397 mGy*cm</p></td></tr><tr><td><p><strong>Rotation time</strong></p></td><td><p>0.25 s</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>not applicable</p></td></tr><tr><td><p><strong>Slice collimation</strong></p></td><td><p>0.4 mm</p></td></tr><tr><td><p><strong>Slice width</strong></p></td><td><p>0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Bv56 Q4</p></td></tr><tr><td><p><strong>keV level</strong></p></td><td><p>55</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>Monoenergetic Plus</p></td></tr><tr><td><p><strong>Heart rate</strong></p></td><td><p>95/min</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iomeron 400, 400 mg/mL</p></td></tr><tr><td><p><strong>Volume</strong></p></td><td><p>95 mL + 10mL saline pacer + 30mL saline chaser</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>5.5 mL/s</p></td></tr><tr><td><p><strong>Start delay</strong></p></td><td><p>Bolus tracking triggered at 140 HU (CCTA)</p></td></tr></table></div><p></p><h2 data-id="disclaimer">DISCLAIMER</h2><p>The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer’s unique setting. Because there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.</p><p>The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.</p>]]>
        </description>
    </item>
    <item>
        <title>PCCT for myocardial tissue characterization in acute myocarditis: comparison with CMR</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/512/pcct-for-myocardial-tissue-characterization-in-acute-myocarditis-comparison-with-cmr</link>
        <pubDate>Mon, 28 Sep 2026 20:07:05 +0000</pubDate>
        <category>Case reports</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">512@/en/discussions</guid>
        <description><![CDATA[<p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/0NA911YUF6CE\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:285496,&quot;width&quot;:581,&quot;height&quot;:339,&quot;displaySize&quot;:&quot;inline&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F0NA911YUF6CE%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1720,&quot;dateInserted&quot;:&quot;2026-09-03T08:59:40+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_inline&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F0NA911YUF6CE%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/0NA911YUF6CE/image.png" alt="image.png" height="339" width="581" data-display-size="inline" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/0NA911YUF6CE/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/0NA911YUF6CE/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/0NA911YUF6CE/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/0NA911YUF6CE/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/0NA911YUF6CE/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/0NA911YUF6CE/image.png 2000w, https://us.v-cdn.net/6038601/uploads/0NA911YUF6CE/image.png" sizes="100vw" /></a>
    </span>
</span>
 </p><h3 data-id="ferenc-imre-suhai-barbara-sipos-milan-vecsey-nagy-balint-szilveszter">Ferenc Imre Suhai, Barbara Sipos, Milán Vecsey-Nagy, Bálint Szilveszter<br /></h3><h4 data-id="varosmajor-heart-and-vascular-centre-cardiac-ct-working-group-budapest-hungary">Városmajor Heart and Vascular Centre, Cardiac CT Working Group, Budapest, Hungary</h4><h4 data-id="september-29-2026">September 29, 2026</h4><p></p><div data-embedjson="{&quot;height&quot;:&quot;360&quot;,&quot;width&quot;:&quot;640&quot;,&quot;isKnowledge&quot;:false,&quot;url&quot;:&quot;https:\/\/siemens-healthineers.bynder.com\/asset\/2a67d11b-415e-4e25-a74a-42d82ff7a4d5\/CT-NAEOTOM-CONNECT-CaseReport-BalintMyocard-1-VIDEO-2026.mp4&quot;,&quot;embedType&quot;:&quot;iframe&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fsiemens-healthineers.bynder.com%2Fasset%2F2a67d11b-415e-4e25-a74a-42d82ff7a4d5%2FCT-NAEOTOM-CONNECT-CaseReport-BalintMyocard-1-VIDEO-2026.mp4" rel="nofollow noopener ugc">
        https://siemens-healthineers.bynder.com/asset/2a67d11b-415e-4e25-a74a-42d82ff7a4d5/CT-NAEOTOM-CONNECT-CaseReport-BalintMyocard-1-VIDEO-2026.mp4
    </a>
</div><div data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/3BV4MQZ2KVN7\/26-358-cr-photoncountingct-myocardial-tissue.pdf&quot;,&quot;name&quot;:&quot;26-358_CR_PhotonCountingCT_Myocardial_Tissue.pdf&quot;,&quot;type&quot;:&quot;application\/pdf&quot;,&quot;size&quot;:619666,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F3BV4MQZ2KVN7%2F26-358-cr-photoncountingct-myocardial-tissue.pdf&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1723,&quot;dateInserted&quot;:&quot;2026-09-03T09:10:09+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;file&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <a rel="nofollow" href="https://connect.siemens-healthineers.com/api/v2/media/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F3BV4MQZ2KVN7%2F26-358-cr-photoncountingct-myocardial-tissue.pdf" download="" aria-label="26-358_CR_PhotonCountingCT_Myocardial_Tissue.pdf">
        26-358_CR_PhotonCountingCT_Myocardial_Tissue.pdf
    </a>
</div>
<h2 data-id="history">History</h2><h4 data-id="why-did-the-patient-come-for-a-ct-exam">Why did the patient come for a CT exam?</h4><p>A 29-year-old male patient, with a history of hypertension and bronchial asthma, was referred to the Városmajor Heart and Vascular Centre from the emergency department due to acute retrosternal chest pain and markedly elevated cardiac biomarkers.</p><p>His symptoms occurred in the setting of a recent upper respiratory tract infection with fever and follicular tonsillitis. He had been treated with azithromycin before admission.</p><p>At the emergency department, laboratory tests showed significant inflammatory activity and myocardial injury, with elevated C-reactive protein, leukocytosis with neutrophilia, and markedly elevated high-sensitivity troponin T, which increased from 1302 ng/L to 1689 ng/L. CK-MB was also elevated.</p><p>Electrocardiography showed ST-segment elevation in the inferior leads with reciprocal ST depression in aVL.</p><p>Transthoracic echocardiography revealed preserved left ventricular systolic function without regional wall motion abnormalities. Given the combination of acute chest pain, elevated troponin, inflammatory syndrome, and ECG changes, acute myocarditis was suspected; however, acute coronary syndrome had to be excluded.</p><p>Therefore, a coronary CT angiography was performed as the initial imaging modality to assess the coronary status. Cardiac magnetic resonance imaging was subsequently performed for detailed myocardial tissue characterization and confirmation of the diagnosis.</p><p></p><h2 data-id="diagnosis">Diagnosis</h2><h4 data-id="what-were-the-ct-findings-and-what-happened-to-the-patient-after-ct">What were the CT findings, and what happened to the patient after CT?</h4><p>Coronary CT angiography was performed using a photon-counting detector CT on a Siemens NAEOTOM Alpha Peak scanner. Native calcium scoring, contrast-enhanced ECG-gated coronary CTA, and a 6-minute delayed-phase acquisition for myocardial tissue characterization and visual assessment of late iodine enhancement were performed.</p><p>The estimated radiation dose was 350 mGy·cm for the CCTA and 245 mGy·cm for the delayed scan.</p><p>Iomeron 400 was administered with a contrast volume of 80 mL. The patient received 75 mg oral metoprolol and 0.8 mg sublingual nitroglycerin prior to the examination. Heart rate during the scan was 85/min with sinus rhythm.</p><p>The coronary calcium score was 0.</p><p>The patient had a left-dominant coronary artery system and normal origin and course of the coronary arteries. No relevant coronary atherosclerosis or luminal stenosis were detected (Figure 1).</p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/EXORB42PL2G3\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:519928,&quot;width&quot;:1091,&quot;height&quot;:641,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FEXORB42PL2G3%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1717,&quot;dateInserted&quot;:&quot;2026-09-03T08:57:07+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FEXORB42PL2G3%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/EXORB42PL2G3/image.png" alt="image.png" height="641" width="1091" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/EXORB42PL2G3/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/EXORB42PL2G3/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/EXORB42PL2G3/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/EXORB42PL2G3/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/EXORB42PL2G3/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/EXORB42PL2G3/image.png 2000w, https://us.v-cdn.net/6038601/uploads/EXORB42PL2G3/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1. </strong>CT coronary angiography demonstrating normal coronary artery anatomy with no evidence of significant stenosis.</p><p></p><p>Cardiac magnetic resonance imaging was performed on a 1.5-T Siemens Aera scanner. Short-axis images demonstrate myocardial edema on T2-weighted fat-suppressed imaging and corresponding non-ischemic late gadolinium enhancement on LGE imaging in the mid-ventricular anterior-anterolateral and inferior-inferolateral left ventricular segments, predominantly in a subepicardial to midmyocardial distribution.</p><p>The concordant presence of edema and LGE supports acute myocarditis rather than ischemic infarction.</p><p>On the 6-minute delayed-phase PCCT images, visually detectable late iodine enhancement was observed, in a non-ischemic distribution. The enhancement involved the basal and midventricular anterolateral and inferolateral regions, the inferior segment in a subepicardial to midmyocardial pattern, and the apical inferior and lateral segments (Figure 2).</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/AMJGJSANT6IR\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:285496,&quot;width&quot;:581,&quot;height&quot;:339,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FAMJGJSANT6IR%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1718,&quot;dateInserted&quot;:&quot;2026-09-03T08:57:48+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FAMJGJSANT6IR%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/AMJGJSANT6IR/image.png" alt="image.png" height="339" width="581" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/AMJGJSANT6IR/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/AMJGJSANT6IR/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/AMJGJSANT6IR/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/AMJGJSANT6IR/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/AMJGJSANT6IR/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/AMJGJSANT6IR/image.png 2000w, https://us.v-cdn.net/6038601/uploads/AMJGJSANT6IR/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2. </strong>Electrocardiogram (ECG) During Prospective Sequential Cardiac CT Acquisition. Multimodality comparison of an acute myocardial injury from basal to apical short-axis images. The first column shows 6-minute delayed-phase PCCT images, the second column shows corresponding color-coded LUT maps, the third column shows iodine maps, and the fourth column shows matched cardiac MRI late gadolinium enhancement images. Blue arrows indicate areas of abnormal myocardial iodine enhancement on PCCT and corresponding non-ischemic myocardial injury on CMR. The abnormalities are predominantly located in the anterolateral, inferolateral, and inferior left ventricular segments, with a subepicardial to midmyocardial distribution, consistent with acute myocarditis.</p><p></p><p>The visual delayed iodine enhancement pattern indicated abnormal myocardial tissue characteristics and supported the diagnosis of an acute myocarditis.</p><p>Cardiac magnetic resonance (CMR) imaging was performed on a 1.5-T Siemens Aera scanner using Gadovist contrast agent. The CMR protocol included cine b-SSFP imaging, T2-weighted imaging, native T1 and T2 mapping, first-pass perfusion, late gadolinium enhancement imaging, and post-contrast T1 mapping for extracellular volume assessment.</p><p>CMR demonstrated mildly reduced left ventricular systolic function, with an LVEF of 45.4%. Left ventricular volumes were within the normal range, stroke volume was preserved, and left ventricular myocardial mass was normal. Right ventricular size and systolic function were preserved, with an RVEF of 52.2%.</p><p>T2-weighted images demonstrated myocardial edema in the basal and midventricular anterolateral and inferolateral segments, the midventricular inferior and partly anterior segments, and the apical inferior segment, predominantly in a subepicardial to midmyocardial distribution (Figure 3).</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/X3RIEB831IY0\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:146490,&quot;width&quot;:898,&quot;height&quot;:383,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FX3RIEB831IY0%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1719,&quot;dateInserted&quot;:&quot;2026-09-03T08:59:00+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FX3RIEB831IY0%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/X3RIEB831IY0/image.png" alt="image.png" height="383" width="898" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/X3RIEB831IY0/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/X3RIEB831IY0/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/X3RIEB831IY0/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/X3RIEB831IY0/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/X3RIEB831IY0/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/X3RIEB831IY0/image.png 2000w, https://us.v-cdn.net/6038601/uploads/X3RIEB831IY0/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3. </strong>Cardiac MRI confirmation of acute myocarditis: myocardial edema and non-ischemic injury</p><p></p><p>After gadolinium administration, pathological late gadolinium enhancement was observed in the same edematous myocardial segments.</p><p>Parametric mapping further supported the diagnosis. Native T1, T2, and ECV values were elevated in the affected lateral myocardial regions. ECV was increased in the basal lateral wall and midventricular lateral wall, while septal values remained within the normal range.</p><p>Overall, the CMR findings confirmed acute myocarditis with mildly reduced left ventricular ejection fraction and mild diffuse hypokinesis.</p><p></p><h2 data-id="comments">Comments</h2><h4 data-id="is-there-any-clinically-interesting-aspect-of-the-case-to-discuss-what-difference-did-photon-counting-ct-make-for-the-patient">Is there any clinically interesting aspect of the case to discuss? <br />
What difference did photon-counting CT make for the patient?</h4><p>This case highlights the potential diagnostic value of photon-counting CT in patients presenting with acute chest pain, elevated cardiac biomarkers, and electrocardiographic changes suggestive of acute coronary syndrome.</p><p>The 6-minute delayed-phase acquisition allowed visual assessment of myocardial iodine retention. Delayed-phase spectral reconstruction using monoenergetic plus images and color-coded iodine maps improved visualization of myocardial iodine distribution and enabled myocardial tissue characterization.</p><p>Focal subepicardial to mid-myocardial iodine accumulation indicated abnormal myocardial tissue characteristics. The distribution of delayed iodine enhancement corresponded closely to the edema, late gadolinium enhancement, and elevated CMR-derived ECV values in the affected myocardial segments.</p><p>An important limitation is the additional radiation exposure associated with the delayed-phase of CT imaging. This is particularly relevant in young patients, in whom radiation dose should be carefully justified and minimized.</p><p>Therefore, delayed-phase PCCT acquisitions should not be considered for routine in all patients with suspected myocarditis, but rather reserved for selected cases in which the expected diagnostic benefit outweighs the additional dose, such as when CMR is contraindicated, unavailable, or unlikely to be feasible.</p><p>PCCT could serve as a comprehensive first-line imaging tool in selected patients with suspected myocarditis and possible acute coronary syndrome. Its inherent spectral capabilities, together with its high spatial resolution, allow rapid exclusion of obstructive coronary artery disease while also enabling visual myocardial tissue characterization through delayed-phase spectral imaging, monoenergetic reconstructions, and iodine mapping.</p><p>These capabilities support comprehensive coronary artery evaluation while simultaneously providing additional insights into myocardial tissue characteristics within a single examination.</p><p></p><h2 data-id="examination-protocol">Examination Protocol</h2><p></p><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha.Peak</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Heart</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>QuantumPlus + HD (combined spectral and HighRes)</p></td></tr><tr><td><p><strong>Scan length</strong></p></td><td><p>141 mm</p></td></tr><tr><td><p><strong>Scan direction</strong></p></td><td><p>Cranio-caudal</p></td></tr><tr><td><p><strong>Scan time</strong></p></td><td><p>0.507 s</p></td></tr><tr><td><p><strong>Tube voltage</strong></p></td><td><p>140 kV</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>100</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>CTDIvol</strong></p></td><td><p>17.5 mGy</p></td></tr><tr><td><p><strong>DLP</strong></p></td><td><p>245 mGy*cm</p></td></tr><tr><td><p><strong>Rotation time</strong></p></td><td><p>0.25 s</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>not applicable</p></td></tr><tr><td><p><strong>Slice collimation</strong></p></td><td><p>144 x 0.4 mm</p></td></tr><tr><td><p><strong>Slice width</strong></p></td><td><p>0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction increment</strong></p></td><td><p>0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction kernel</strong></p></td><td><p>Qr44 Q4</p></td></tr><tr><td><p><strong>keV level</strong></p></td><td><p>40</p></td></tr><tr><td><p><strong>Spectral reconstruction</strong></p></td><td><p>Monoenergetic Plus; iodine/water decomposition; iodine maps</p></td></tr><tr><td><p><strong>Heart rate</strong></p></td><td><p>57/min (delayed)</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iomeron 400, 400 mg/mL</p></td></tr><tr><td><p><strong>Volume</strong></p></td><td><p>80 mL + 10mL saline pacer + 30mL saline chaser (for CCTA)</p></td></tr><tr><td><p><strong>Flow rate</strong></p></td><td><p>5 mL/s</p></td></tr><tr><td><p><strong>Start delay</strong></p></td><td><p>Bolus tracking triggered at 92 HU (CCTA), delayed acquisition performed 6 minutes after contrast administration.</p></td></tr></table></div><p></p><h2 data-id="disclaimer">Disclaimer</h2><p>The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer’s unique setting. Because there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.</p><p>The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Hyska | Time-resolved PCCT estimates post-TAVI pressure gradients</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/534/2026-hyska-time-resolved-pcct-estimates-post-tavi-pressure-gradients</link>
        <pubDate>Mon, 28 Sep 2026 08:03:04 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">534@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In 71 post-TAVI PCCT examinations from 63 patients, time-resolved cardiac PCCT enabled calculation of prosthetic-valve hemodynamics from left-ventricular volumetry and direct valve-orifice planimetry. CT-derived mean and maximum transvalvular gradients correlated strongly with echocardiography (ρ = 0.85 for both), while corrected valve area showed a correlation of ρ = 0.73.</p><p></p><p>The most clinically useful parameter was the mean transvalvular gradient (Pmean). Using echocardiographic Pmean ≥20 mmHg as the reference for potential valve dysfunction, PCCT achieved AUC 0.94, sensitivity 88.9%, specificity 88.6%, and overall accuracy 88.7%. The independently derived optimal PCCT cutoff was almost identical at 20.4 mmHg.</p><p></p><p>PCCT-derived Pmean showed much better agreement than Pmax: mean Pmean bias was only 1.6 mmHg, whereas Pmax was systematically higher and showed wider limits of agreement. This suggests that a post-TAVI PCCT already obtained for structural assessment could potentially provide opportunistic functional valve assessment, although the retrospective single-center workflow still requires external validation.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.journalofcardiovascularct.com%2Farticle%2FS1934-5925%2826%2900484-3%2Ffulltext" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/CGFSADE94G8J\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:5318603,&quot;width&quot;:3354,&quot;height&quot;:1877,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FCGFSADE94G8J%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1800,&quot;dateInserted&quot;:&quot;2026-09-28T08:01:31+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FCGFSADE94G8J%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/CGFSADE94G8J/image.png" alt="image.png" height="1877" width="3354" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/CGFSADE94G8J/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/CGFSADE94G8J/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/CGFSADE94G8J/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/CGFSADE94G8J/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/CGFSADE94G8J/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/CGFSADE94G8J/image.png 2000w, https://us.v-cdn.net/6038601/uploads/CGFSADE94G8J/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1. </strong>Schematic overview of the CT-based workflow for post-TAVI hemodynamic assessment. Time-resolved cardiac CT was used to derive prosthetic valve hemodynamics after TAVI by combining multiphase left-ventricular volumetry, valve orifice area planimetry, quality control for excluding cases with severe mitral regurgitation and hemodynamic modeling of transvalvular flow.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Cardiac / post-TAVI prosthetic valve</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Quantum HD</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>Retrospectively ECG-gated spiral</p></td></tr><tr><td><p><strong>Tube voltage [kVp]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>60</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>Automatic tube-current modulation; ECG-based modulation at 30–70% RR</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>44.1 ± 13.6</p></td></tr><tr><td><p><strong>DLP [mGy·cm]</strong></p></td><td><p>670.0 [476.0–849.5]</p></td></tr><tr><td><p><strong>Effective dose [mSv]</strong></p></td><td><p>17.4 [12.4–22.1]</p></td></tr><tr><td><p><strong>Rotation time [ms]</strong></p></td><td><p>250</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>120 × 0.2 mm</p></td></tr><tr><td><p><strong>Temporal reconstruction</strong></p></td><td><p>Full cardiac cycle at 10% RR increments</p></td></tr><tr><td><p><strong>Pressure-curve temporal sampling</strong></p></td><td><p>Resampled to 66 ms</p></td></tr><tr><td><p><strong>Volumetry reconstruction</strong></p></td><td><p>Bv36; 0.8/0.6-mm thickness/increment; </p><p>512 × 512; </p><p>QIR 3</p></td></tr><tr><td><p><strong>Valve-orifice reconstruction</strong></p></td><td><p>BMI-adapted Bv60/Bv64; </p><p>0.2/0.1-mm thickness/increment; </p><p>512 × 512; QIR 4</p></td></tr><tr><td><p><strong>Valve phase</strong></p></td><td><p>Automatically selected best systolic phase</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iodinated contrast, 350–370 mg I/mL</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>75 mL</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>3 mL/s</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>Ascending aorta</p></td></tr><tr><td><p><strong>Post-processing</strong></p></td><td><p>Multiphase LV volumetry + prosthetic-valve orifice planimetry</p></td></tr><tr><td><p><strong>Hemodynamic model</strong></p></td><td><p>Flow/velocity calculation followed by simplified Bernoulli equation</p></td></tr><tr><td><p><strong>Severe mitral regurgitation exclusion</strong></p></td><td><p>CT-derived mitral regurgitation fraction &gt;40%</p></td></tr></table></div><p> </p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>71 scans / 63 patients</strong></p></td></tr><tr><td><p><strong>Pmean correlation with TTE</strong></p></td><td><p><strong>ρ = 0.85</strong>, <em>p</em> &lt; 0.001</p></td></tr><tr><td><p><strong>Pmean agreement</strong></p></td><td><p>CT <strong>20.2 [13.4–27.6]</strong> vs TTE <strong>20.0 [16.0–24.5] mmHg</strong>, <em>p</em> = 0.080; </p><p>bias <strong>1.6 mmHg</strong></p></td></tr><tr><td><p><strong>Valve-dysfunction detection</strong></p></td><td><p><strong>AUC 0.94</strong>, sensitivity <strong>88.9%</strong>, specificity <strong>88.6%</strong>, accuracy <strong>88.7%</strong></p></td></tr><tr><td><p><strong>Optimal PCCT Pmean cutoff</strong></p></td><td><p><strong>20.4 mmHg</strong></p></td></tr><tr><td><p><strong>Longitudinal follow-up</strong></p></td><td><p>Pmean change correlated with TTE (<strong>ρ = 0.80</strong>); all <strong>8/8</strong> paired follow-ups concordantly classified around the 20-mmHg threshold</p></td></tr></table></div><p> </p><p><strong>Source:</strong><br />
Hyska S, Osoria-Velasquez J, Hagar MT, et al. <em>Photon-counting detector CT for prediction of valve dysfunction after transcatheter aortic valve implantation: Comparison with echocardiography.</em> <strong>Journal of Cardiovascular Computed Tomography.</strong> Articles in Press. Published September 18, 2026.</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Pali | PCCT iodine maps quantify when post-thrombectomy staining becomes visible</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/533/2026-pali-pcct-iodine-maps-quantify-when-post-thrombectomy-staining-becomes-visible</link>
        <pubDate>Mon, 28 Sep 2026 07:42:23 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">533@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In 12 patients after mechanical thrombectomy, 54 ASPECTS regions ultimately developed infarction; 40/54 (74.1%) showed hyperattenuation on PCCT iodine maps, but only 15/40 (37.5%) were visually hyperattenuating on conventional brain-window images. Thus, iodine accumulation was frequently measurable before becoming visually apparent on routine grayscale CT.</p><p><br />
PCCT iodine-map attenuation very accurately predicted conventional brain-window visibility (AUC 0.997). An internally derived threshold of 8.33 HU provided 100% sensitivity and 96% specificity; patient-level bootstrap analysis yielded a median cutoff of 11.69 HU with a 95% interval of 8.33–12.67 HU.</p><p><br />
The relative brain-window attenuation increase also performed well (AUC 0.984; threshold 3.06%), but showed substantially greater cutoff variability. The practical implication is that direct iodine quantification may provide a more robust and reproducible marker of post-thrombectomy contrast staining than visual assessment alone, although the thresholds remain pilot estimates requiring external validation.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.mdpi.com%2F2075-4418%2F16%2F18%2F2915" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/9R9BXTCBSQFF\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:3414671,&quot;width&quot;:3128,&quot;height&quot;:2379,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9R9BXTCBSQFF%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1799,&quot;dateInserted&quot;:&quot;2026-09-28T07:39:14+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9R9BXTCBSQFF%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/9R9BXTCBSQFF/image.png" alt="image.png" height="2379" width="3128" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/9R9BXTCBSQFF/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/9R9BXTCBSQFF/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/9R9BXTCBSQFF/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/9R9BXTCBSQFF/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/9R9BXTCBSQFF/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/9R9BXTCBSQFF/image.png 2000w, https://us.v-cdn.net/6038601/uploads/9R9BXTCBSQFF/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1.</strong> Examples of IM hyperattenuating areas that are clearly hyperattenuating on BW images (a,b), only mildly hyperattenuating on BW images (c,d), or not clearly hyperattenuating on BW images (e,f).</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha.Peak</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Brain</p></td></tr><tr><td><p><strong>Reconstructions</strong></p></td><td><p>Brain window, iodine map, virtual non-contrast</p></td></tr><tr><td><p><strong>Follow-up imaging</strong></p></td><td><p>Non-contrast CT approximately 24 h after PCCT</p></td></tr><tr><td><p><strong>Reference for infarction extent</strong></p></td><td><p>Follow-up CT using ASPECTS</p></td></tr><tr><td><p><strong>Hemorrhage assessment</strong></p></td><td><p>Virtual non-contrast images</p></td></tr><tr><td><p><strong>ROI analysis</strong></p></td><td><p>Three circular 10 mm² ROIs per affected ASPECTS region</p></td></tr><tr><td><p><strong>Reference ROI</strong></p></td><td><p>Matching contralateral region at the same axial level</p></td></tr><tr><td><p><strong>Quantitative metric</strong></p></td><td><p>Iodine-map attenuation and relative brain-window attenuation increase (%ΔHU)</p></td></tr><tr><td><p><strong>Threshold analysis</strong></p></td><td><p>ROC analysis with patient-level clustered bootstrap resampling, 2000 iterations</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>12 patients</strong>, 54 ASPECTS regions with final infarction</p></td></tr><tr><td><p><strong>Iodine-map positive regions</strong></p></td><td><p><strong>40/54 (74.1%)</strong></p></td></tr><tr><td><p><strong>Visible on brain-window images</strong></p></td><td><p><strong>15/40 (37.5%)</strong></p></td></tr><tr><td><p><strong>Iodine-map threshold</strong></p></td><td><p><strong>8.33 HU</strong>; AUC <strong>0.997</strong>, sensitivity <strong>100%</strong>, specificity <strong>96.0%</strong></p></td></tr><tr><td><p><strong>Relative BW threshold</strong></p></td><td><p><strong>3.06%</strong>; AUC <strong>0.984</strong>, sensitivity <strong>100%</strong>, specificity <strong>92.0%</strong></p></td></tr><tr><td><p><strong>Inter-reader agreement</strong></p></td><td><p>κ <strong>0.81</strong> for iodine maps; κ <strong>0.86</strong> for brain-window visibility</p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Pali M-C, Mangesius S, Eisenschink CE, Deisl P, Neumann L, Knoflach M, Pechlaner R, Glodny B, Lenhart L, Gizewski ER, Grams AE. <em>From Iodine Maps to Brain Window Images: Quantitative Visibility Thresholds of Iodine Staining Using Photon-Counting CT—A Retrospective Observational Study.</em> <strong>Diagnostics.</strong> 2026;16(18):2915. doi:10.3390/diagnostics16182915.</p>]]>
        </description>
    </item>
    <item>
        <title>(2025) Mark | PCCT for Cushing Disease: Lesion localization, intraoperative findings, and outcomes</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/528/2025-mark-pcct-for-cushing-disease-lesion-localization-intraoperative-findings-and-outcomes</link>
        <pubDate>Wed, 23 Sep 2026 08:17:26 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">528@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In 25 consecutive patients with Cushing disease undergoing transsphenoidal surgery, dynamic pituitary PCCT localized corticotroph adenomas substantially more accurately than preoperative MRI: 92% vs 56%, respectively (p = .01). PCCT identified a lesion in 24/25 patients, with only one misleading localization. </p><p></p><p>The gain was particularly relevant in MRI-negative or misleading cases. Imaging-guided targeted resection was used in 20/25 patients, and in 6 cases the surgical target relied solely on PCCT, potentially avoiding wider gland exploration or subtotal resection. </p><p></p><p>Clinical outcomes were encouraging: 84% remained in biochemical remission at a mean 5.8-month follow-up, with no new panhypopituitarism or central diabetes insipidus reported. However, this was a small, retrospective, nonblinded single-center study, so PCCT should currently be viewed as complementary to MRI rather than a replacement.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.ajnr.org%2Fcontent%2F46%2F12%2F2610" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/9CBV0QWR7OKV\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:733512,&quot;width&quot;:1000,&quot;height&quot;:575,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9CBV0QWR7OKV%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1758,&quot;dateInserted&quot;:&quot;2026-09-23T08:14:45+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9CBV0QWR7OKV%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/9CBV0QWR7OKV/image.png" alt="image.png" height="575" width="1000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/9CBV0QWR7OKV/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/9CBV0QWR7OKV/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/9CBV0QWR7OKV/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/9CBV0QWR7OKV/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/9CBV0QWR7OKV/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/9CBV0QWR7OKV/image.png 2000w, https://us.v-cdn.net/6038601/uploads/9CBV0QWR7OKV/image.png" sizes="100vw" /></a>
    </span>
</span>
<span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/5Q2DE53E4C22\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:168645,&quot;width&quot;:440,&quot;height&quot;:255,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F5Q2DE53E4C22%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1757,&quot;dateInserted&quot;:&quot;2026-09-23T08:12:37+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F5Q2DE53E4C22%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/5Q2DE53E4C22/image.png" alt="image.png" height="255" width="440" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/5Q2DE53E4C22/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/5Q2DE53E4C22/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/5Q2DE53E4C22/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/5Q2DE53E4C22/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/5Q2DE53E4C22/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/5Q2DE53E4C22/image.png 2000w, https://us.v-cdn.net/6038601/uploads/5Q2DE53E4C22/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3. </strong>llustrative case 2. Dynamic (<em>A</em>) and delayed (<em>B</em> and <em>C</em>) contrast-enhanced T1-weighted images at 3T demonstrate a hypoenhancing lesion in the left pituitary (<em>blue arrows</em>). This area is more conspicuous on color-coded iodine maps from the PCD-CT (<em>D–F</em>, <em>white arrows</em>).</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Skull base / pituitary gland</p></td></tr><tr><td><p><strong>Acquisition protocol</strong></p></td><td><p>Triggered skull base CTA followed by 4–6 delayed sellar acquisitions</p></td></tr><tr><td><p><strong>Delayed acquisition interval</strong></p></td><td><p>20 s</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>230 for CTA</p></td></tr><tr><td><p><strong>Effective mAs</strong></p></td><td><p>130–200 for delayed sellar scans</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>CTA: 27.2–43.5; </p><p>delayed sellar scans: 22.2–34.3</p></td></tr><tr><td><p><strong>Detector configuration</strong></p></td><td><p>120 × 0.2 mm</p></td></tr><tr><td><p><strong>Reconstruction slice thickness [mm]</strong></p></td><td><p>0.6 and 0.2</p></td></tr><tr><td><p><strong>Kernel</strong></p></td><td><p>Hr40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 3</p></td></tr><tr><td><p><strong>0.6-mm reconstruction</strong></p></td><td><p>66-keV VMI</p></td></tr><tr><td><p><strong>0.2-mm reconstruction</strong></p></td><td><p>T3D, low-energy threshold</p></td></tr><tr><td><p><strong>Iodine maps</strong></p></td><td><p>Qr40, 0.4-mm slice thickness</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iohexol 350</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>100 mL</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>4 mL/s</p></td></tr><tr><td><p><strong>Saline flush</strong></p></td><td><p>35 mL for patients &lt;136 kg</p></td></tr><tr><td><p><strong>Bolus trigger</strong></p></td><td><p>Ascending aorta, 175 HU at 90 kV</p></td></tr><tr><td><p><strong>Image review</strong></p></td><td><p>Visage PACS with color-coded display</p></td></tr></table></div><p></p><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>25 patients</strong> with surgically treated Cushing disease</p></td></tr><tr><td><p><strong>MRI localization accuracy</strong></p></td><td><p><strong>56%</strong></p></td></tr><tr><td><p><strong>PCCT localization accuracy</strong></p></td><td><p><strong>92%</strong>, <em>p</em> = .01 vs MRI</p></td></tr><tr><td><p><strong>PCCT lesion detection</strong></p></td><td><p><strong>24/25 (96%)</strong>; 1 misleading localization</p></td></tr><tr><td><p><strong>Targeted surgery</strong></p></td><td><p><strong>20/25 (80%)</strong>; 6 relied solely on PCCT localization</p></td></tr><tr><td><p><strong>Remission at follow-up</strong></p></td><td><p><strong>84%</strong> at mean 5.8 months</p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Mark IT, Michalopoulos G, Van Gompel J, Peris Celda M, Bancos I, Donegan D, Gruber L, Erickson D, Nagelschneider A, Yu L. <em>Pituitary Photon-Counting Detector CT for Cushing Disease: Preoperative Lesion Localization, Intraoperative Findings, and Postoperative Outcomes.</em> <strong>American Journal of Neuroradiology.</strong> 2025;46(12):2610–2616. doi:10.3174/ajnr.A8893. </p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Limantoro | Ultra-low dose pediatric chest PCCT approaching chest radiograph doses</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/524/2026-limantoro-ultra-low-dose-pediatric-chest-pcct-approaching-chest-radiograph-doses</link>
        <pubDate>Mon, 21 Sep 2026 07:08:14 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">524@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In this feasibility study, an ultra-low-dose pediatric chest PCCT protocol was optimized to Sn100 kVp, 2 mAs, pitch 1.5, achieving a phantom effective dose of 14 µSv. In clinical use, the median total effective dose was 11.6 µSv, close to the 8.2 µSv median dose of a single chest radiograph.</p><p><br />
The protocol was applied in 24 examinations in 20 children, median age 10 years, and every examination provided sufficient confidence to answer the immediate clinical question. Image quality was strongest for focal abnormalities, known-lesion follow-up, congenital diaphragmatic hernia follow-up, and assessment of ILD progression.</p><p><br />
The trade-off is task specificity: readers were less confident when using this ultra-low-dose protocol to rule out previously unknown ILD or bronchiectasis. The authors therefore position it as a targeted follow-up tool rather than a replacement for standard-dose chest CT when subtle diffuse lung disease must be excluded.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1186%2Fs41747-026-00783-2" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/9IEBGPGKSEN1\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:888299,&quot;width&quot;:1298,&quot;height&quot;:735,&quot;displaySize&quot;:&quot;medium&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9IEBGPGKSEN1%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1752,&quot;dateInserted&quot;:&quot;2026-09-21T07:02:16+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9IEBGPGKSEN1%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/9IEBGPGKSEN1/image.png" alt="image.png" height="735" width="1298" data-display-size="medium" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/9IEBGPGKSEN1/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/9IEBGPGKSEN1/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/9IEBGPGKSEN1/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/9IEBGPGKSEN1/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/9IEBGPGKSEN1/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/9IEBGPGKSEN1/image.png 2000w, https://us.v-cdn.net/6038601/uploads/9IEBGPGKSEN1/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2. </strong>CT scans during follow-up of a patient known with a coiled pulmonary AV malformation in the left upper lobe (red arrow). Axial (<strong>a</strong>) and coronal (<strong>b</strong>) images obtained on energy-integrating-detector CT (with intravenous contrast) when the patient was 9 years old (CTDI 3.43 mGy, SSDE 6 mGy, WED 20.5 cm). Axial (<strong>c</strong>) and coronal (<strong>d</strong>) images obtained on PCCT using ULDCT protocol (without intravenous contrast) when the patient was 13 years old (CTDI 0.01 mGy, SSDE 0.02 mGy, WED 22.5 cm).</p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/QNXH5X5M3WB3\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:101181,&quot;width&quot;:1271,&quot;height&quot;:577,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FQNXH5X5M3WB3%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1753,&quot;dateInserted&quot;:&quot;2026-09-21T07:03:30+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FQNXH5X5M3WB3%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/QNXH5X5M3WB3/image.png" alt="image.png" height="577" width="1271" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/QNXH5X5M3WB3/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/QNXH5X5M3WB3/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/QNXH5X5M3WB3/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/QNXH5X5M3WB3/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/QNXH5X5M3WB3/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/QNXH5X5M3WB3/image.png 2000w, https://us.v-cdn.net/6038601/uploads/QNXH5X5M3WB3/image.png" sizes="100vw" /></a>
    </span>
</span>
<p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Pediatric chest</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Ultra-low-dose PCCT</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Noncontrast</p></td></tr><tr><td><p><strong>Tube voltage [kVp]</strong></p></td><td><p>Sn100</p></td></tr><tr><td><p><strong>Tube current-exposure product [mAs]</strong></p></td><td><p>2</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>1.5</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25</p></td></tr><tr><td><p><strong>Detector z-coverage</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Focal spot [mm]</strong></p></td><td><p>0.8 × 1.2</p></td></tr><tr><td><p><strong>FOV [mm]</strong></p></td><td><p>350</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>Pixel size [mm]</strong></p></td><td><p>0.68</p></td></tr><tr><td><p><strong>Reconstruction energy</strong></p></td><td><p>73-keV VMI</p></td></tr><tr><td><p><strong>Lung kernel</strong></p></td><td><p>Bl56</p></td></tr><tr><td><p><strong>Soft-tissue kernel</strong></p></td><td><p>Br40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 4</p></td></tr><tr><td><p><strong>Lung slice thickness [mm]</strong></p></td><td><p>1</p></td></tr><tr><td><p><strong>Soft-tissue slice thickness [mm]</strong></p></td><td><p>3</p></td></tr><tr><td><p><strong>Clinical CTDIvol [mGy]</strong></p></td><td><p>~0.01</p></td></tr><tr><td><p><strong>Clinical SSDE [mGy]</strong></p></td><td><p>0.019 ± 0.002</p></td></tr><tr><td><p><strong>Total effective dose [µSv]</strong></p></td><td><p>Median 11.6 [IQR 10.9–12.8]</p></td></tr><tr><td><p><strong>Scout contribution [µSv]</strong></p></td><td><p>1.7 [IQR 1.5–1.8]</p></td></tr><tr><td><p><strong>CT-series contribution [µSv]</strong></p></td><td><p>9.9 [IQR 9.4–11.1]</p></td></tr></table></div><p></p><p>  </p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Clinical cohort</strong></p></td><td><p><strong>24 scans in 20 children</strong>; median age <strong>10 years</strong></p></td></tr><tr><td><p><strong>Median total PCCT dose</strong></p></td><td><p><strong>11.6 µSv</strong> [IQR 10.9–12.8]</p></td></tr><tr><td><p><strong>Chest radiograph dose</strong></p></td><td><p><strong>8.2 µSv</strong> [IQR 6.2–13.6], <em>p</em> = 0.007</p></td></tr><tr><td><p><strong>Immediate diagnostic adequacy</strong></p></td><td><p><strong>All 24 scans</strong> sufficient without immediate repeat standard-dose CT</p></td></tr><tr><td><p><strong>Best-rated indications</strong></p></td><td><p>Focal abnormalities, known-lesion follow-up, congenital diaphragmatic hernia follow-up, ILD follow-up</p></td></tr><tr><td><p><strong>Lower-confidence indications</strong></p></td><td><p>Ruling out previously unknown <strong>ILD or bronchiectasis</strong></p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Limantoro I, Torfs K, Binst J, Proesmans M, Breysem L, Bosmans H, Aertsen M. <em>Next-gen paediatric imaging: ultra-low dose chest photon-counting CT approaching chest radiograph doses.</em> <strong>European Radiology Experimental.</strong> 2026;10:119. doi:10.1186/s41747-026-00783-2.</p>]]>
        </description>
    </item>
    <item>
        <title>(2024) Dettmer | Chest X-ray–dose PCCT changes diagnosis in suspected pneumonia</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/519/2024-dettmer-chest-x-ray-dose-pcct-changes-diagnosis-in-suspected-pneumonia</link>
        <pubDate>Fri, 04 Sep 2026 06:34:23 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">519@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In <strong>27 adults with suspected respiratory infection</strong>, an ultra-low-dose PCCT chest protocol achieved a mean effective dose of <strong>0.11 ± 0.04 mSv</strong>, essentially matching the German reference dose for a two-view chest radiograph. Despite this very low exposure, PCCT provided substantially more diagnostic information than radiography. </p><p></p><p>PCCT <strong>changed the main diagnosis in 11/27 patients (41%)</strong> and <strong>changed therapy in 10/27 (37%)</strong>. It detected previously occult infiltrates in 5 patients, confidently excluded an infiltrate in 10, and provided clinically relevant additional findings in 4. </p><p></p><p>The approach appears most useful when radiography is equivocal or clinical suspicion remains high, particularly in immunosuppressed patients. It is not a complete substitute for standard contrast-enhanced CT: <strong>2/27 patients required an additional CT</strong> for suspected pulmonary embolism or pleural empyema. </p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fkarger.com%2Fres%2Farticle%2F103%2F2%2F88%2F894609%2FPhoton-Counting-Computed-Tomography-with-the" rel="nofollow noopener ugc" role="button">Access publication</a></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/JKQ9N8ICB5GD\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:2130691,&quot;width&quot;:900,&quot;height&quot;:2162,&quot;displaySize&quot;:&quot;small&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJKQ9N8ICB5GD%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1731,&quot;dateInserted&quot;:&quot;2026-09-04T06:33:33+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FJKQ9N8ICB5GD%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/JKQ9N8ICB5GD/image.png" alt="image.png" height="2162" width="900" data-display-size="small" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/JKQ9N8ICB5GD/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/JKQ9N8ICB5GD/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/JKQ9N8ICB5GD/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/JKQ9N8ICB5GD/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/JKQ9N8ICB5GD/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/JKQ9N8ICB5GD/image.png 2000w, https://us.v-cdn.net/6038601/uploads/JKQ9N8ICB5GD/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 1. </strong>Comparison of CXR and ULD-CT in 6 patients of our study cohort demonstrating the clinical significance and the limitations of ULD-CT. <strong>a</strong>, <strong>b</strong> Consolidation in the right lower lobe, occult in the CXR hidden behind the right diaphragm. <strong>c</strong>, <strong>d</strong> Bilateral opacities, occult in the CXR due to the low density. <strong>e</strong>, <strong>f</strong> Bilateral opacities in the CXR; the ULD-CT shows the pattern of an organizing pneumonia as additional information. <strong>g</strong>, <strong>h</strong> Bilateral opacities in the CXR; the ULD-CT shows the pattern of sarcoidosis as additional information. <strong>i</strong>, <strong>j</strong> Bilateral opacities in the CXR; the ULD-CT shows pleural masses. <strong>k</strong>, <strong>l</strong> Basal opacities in CXR and consolidation and pleural effusion in ULD-CT; for the diagnosis of a pleural empyema, the ULD-CT was not sufficient and a standard CT with contrast was needed. </p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Chest</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>Ultra-low-dose PCCT</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Unenhanced</p></td></tr><tr><td><p><strong>Breathing</strong></p></td><td><p>Full inspiration</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>100</p></td></tr><tr><td><p><strong>Spectral shaping</strong></p></td><td><p>Tin filtration</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>3</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>Flash</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>2</p></td></tr><tr><td><p><strong>Table speed [mm/s]</strong></p></td><td><p>461</p></td></tr><tr><td><p><strong>Scan time</strong></p></td><td><p>&lt;1 s for whole chest</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>Reconstruction slice thickness [mm]</strong></p></td><td><p>1.0</p></td></tr><tr><td><p><strong>Reconstruction increment [mm]</strong></p></td><td><p>0.7</p></td></tr><tr><td><p><strong>Kernel</strong></p></td><td><p>BR40</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>Strength 2</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>0.19 ± 0.05</p></td></tr><tr><td><p><strong>DLP [mGy·cm]</strong></p></td><td><p>6.3 ± 2.1</p></td></tr><tr><td><p><strong>Effective dose [mSv]</strong></p></td><td><p>0.11 ± 0.04</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>27 patients</strong>; median age 68 years; 59% immunosuppressed</p></td></tr><tr><td><p><strong>Mean effective PCCT dose</strong></p></td><td><p><strong>0.11 ± 0.04 mSv</strong></p></td></tr><tr><td><p><strong>Occult infiltrate detected</strong></p></td><td><p><strong>5/27 (19%)</strong></p></td></tr><tr><td><p><strong>Infiltrate confidently excluded</strong></p></td><td><p><strong>10/27 (37%)</strong></p></td></tr><tr><td><p><strong>Main diagnosis changed</strong></p></td><td><p><strong>11/27 (41%)</strong></p></td></tr><tr><td><p><strong>Therapy changed</strong></p></td><td><p><strong>10/27 (37%)</strong></p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Dettmer S, Werncke T, Nikolova Mitkovska V, Brod T, Joean O, Vogel-Claussen J, Wacker F, Welte T, Rademacher J. <em>Photon Counting Computed Tomography with the Radiation Dose of a Chest X-Ray: Feasibility and Diagnostic Yield.</em> <strong>Respiration.</strong> 2024;103(2):88–94. doi:10.1159/000536065.</p>]]>
        </description>
    </item>
    <item>
        <title>(2023) van der Bie | PCCT for TAVR planning and follow-up</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/518/2023-van-der-bie-pcct-for-tavr-planning-and-follow-up</link>
        <pubDate>Fri, 04 Sep 2026 06:28:26 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">518@/en/discussions</guid>
        <description><![CDATA[<div><div><p>This early case series illustrates how <strong>UHR PCCT can improve structural heart imaging before and after TAVR</strong>, particularly through sharper depiction of the aortic valve, annulus, coronary arteries, prosthetic valve frames, and vascular access routes. UHR acquisition allows <strong>0.2-mm sections</strong>, compared with 0.4 mm in the regular PCCT mode, helping reduce calcium and metal blooming.</p><p></p><p>In pre-TAVR imaging, sharper reconstruction improved visualization of heavily calcified coronary arteries and <strong>IMAR substantially improved femoral-artery assessment despite bilateral hip prostheses</strong>. Post-TAVR, PCCT depicted hypoattenuating leaflet thickening, valve-in-valve anatomy, and an incompletely expanded left-main stent with an assessable lumen despite substantial surrounding metal and calcium.</p><p></p><p>The spectral capabilities add information beyond spatial resolution: <strong>VMI, virtual noncontrast, and iodine maps</strong> helped characterize leaflet abnormalities and distinguish iodine from calcification. These are promising proof-of-concept applications, but the report is a small case series rather than a comparative diagnostic-accuracy study. </p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fpubs.rsna.org%2Fdoi%2F10.1148%2Fryct.220318" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/KIY54GCOCYGQ\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:474860,&quot;width&quot;:1000,&quot;height&quot;:575,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKIY54GCOCYGQ%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1730,&quot;dateInserted&quot;:&quot;2026-09-04T06:27:51+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FKIY54GCOCYGQ%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/KIY54GCOCYGQ/image.png" alt="image.png" height="575" width="1000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/KIY54GCOCYGQ/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/KIY54GCOCYGQ/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/KIY54GCOCYGQ/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/KIY54GCOCYGQ/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/KIY54GCOCYGQ/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/KIY54GCOCYGQ/image.png 2000w, https://us.v-cdn.net/6038601/uploads/KIY54GCOCYGQ/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 2</strong>: Photon-counting detector CT scan for pre–transcatheter aortic valve replacement planning in an 81-year-old female patient (with contrast material). <strong>(A)</strong> Electrocardiogram shows a highly irregular heart rate was present at the time of scanning. <strong>(B)</strong> Contrast-enhanced visualization of the aortic annulus and native aortic valve in the sagittal plane with sharp delineation of the leaflets and a small calcification in the nodule of Arantius (white arrow). <strong>(C)</strong> Ultra-high-resolution image shows the coronary arteries (Bv56 kernel, multiplanar reformatted image). <strong>(D)</strong> Conventional reconstructions at 0.6-mm section thickness (Bv40 kernel) for comparison (multiplanar reformatted image). <strong>(E, F)</strong> Axial reconstructions at the level of the femoral arteries (arrows) without <strong>(E)</strong> and with <strong>(F)</strong> iterative metal artifact reduction (IMAR) reconstruction. QIR = quantitative iterative reconstruction. </p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha, dual-source PCCT</p></td></tr><tr><td><p><strong>Regular detector configuration</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>UHR detector configuration</strong></p></td><td><p>120 × 0.2 mm</p></td></tr><tr><td><p><strong>UHR section thickness</strong></p></td><td><p>0.2 mm</p></td></tr><tr><td><p><strong>Pre-TAVR cardiac acquisition, Case 2</strong></p></td><td><p>Prospectively ECG-triggered UHR CTA, 15–53% RR</p></td></tr><tr><td><p><strong>Tube voltage, Case 2 [kVp]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>IQ level, Case 2</strong></p></td><td><p>43</p></td></tr><tr><td><p><strong>CTDIvol, Case 2 cardiac [mGy]</strong></p></td><td><p>26.8</p></td></tr><tr><td><p><strong>Access-route acquisition, Case 2</strong></p></td><td><p>High-pitch skull base to groin, 0.4-mm sections</p></td></tr><tr><td><p><strong>Access-route IQ level</strong></p></td><td><p>41</p></td></tr><tr><td><p><strong>Access-route CTDIvol [mGy]</strong></p></td><td><p>2.45</p></td></tr><tr><td><p><strong>Coronary UHR kernel, Case 2</strong></p></td><td><p>Bv56</p></td></tr><tr><td><p><strong>Comparator reconstruction, Case 2</strong></p></td><td><p>Bv40, 0.6-mm sections</p></td></tr><tr><td><p><strong>Metal artifact reduction</strong></p></td><td><p>IMAR for vascular access assessment</p></td></tr><tr><td><p><strong>Post-TAVR acquisition, Case 3</strong></p></td><td><p>120 kV; IQ 50; CTDIvol 15.2 mGy</p></td></tr><tr><td><p><strong>Spectral post-processing, Case 3</strong></p></td><td><p>VMI, virtual noncontrast, iodine map, fused iodine/VNC</p></td></tr><tr><td><p><strong>Post-TAVR acquisition, Case 4</strong></p></td><td><p>Retrospective ECG-gated UHR; 120 kV; IQ 60; CTDIvol 58 mGy</p></td></tr><tr><td><p><strong>Valve-in-valve acquisition, Case 5</strong></p></td><td><p>Full-cycle retrospective ECG-gated UHR; 120 kV; IQ 65; CTDIvol 61.5 mGy</p></td></tr><tr><td><p><strong>Valve-in-valve reconstruction</strong></p></td><td><p>Bv56; QIR 4</p></td></tr><tr><td><p><strong>Ex vivo valve acquisition</strong></p></td><td><p>UHR, 140 kV</p></td></tr><tr><td><p><strong>Ex vivo reconstruction</strong></p></td><td><p>Qr89/Qr76; QIR 4</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Spatial resolution</strong></p></td><td><p>UHR PCCT enabled <strong>0.2-mm</strong> sections vs <strong>0.4 mm</strong> in regular PCCT mode</p></td></tr><tr><td><p><strong>Pre-TAVR coronary imaging</strong></p></td><td><p>Bv56 UHR reconstruction reduced calcium blooming compared with 0.6-mm Bv40</p></td></tr><tr><td><p><strong>Access-route assessment</strong></p></td><td><p>IMAR improved femoral-artery visualization despite bilateral hip prostheses</p></td></tr><tr><td><p><strong>Leaflet assessment</strong></p></td><td><p>PCCT demonstrated hypoattenuating leaflet thickening after TAVR and valve-in-valve TAVR</p></td></tr><tr><td><p><strong>Coronary stent assessment</strong></p></td><td><p>Left-main stent lumen remained assessable; incomplete expansion from adjacent calcification was visualized</p></td></tr><tr><td><p><strong>Spectral imaging</strong></p></td><td><p>VMI, VNC, and iodine maps provided additional characterization of valve leaflets and calcification</p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
van der Bie J, Sharma SP, van Straten M, Bos D, Hirsch A, Dijkshoorn ML, Adrichem R, van Mieghem NMDA, Budde RPJ. <em>Photon-counting Detector CT in Patients Pre- and Post-Transcatheter Aortic Valve Replacement.</em> <strong>Radiology: Cardiothoracic Imaging.</strong> 2023;5(2). doi:10.1148/ryct.220318. </p>]]>
        </description>
    </item>
    <item>
        <title>(2023) Turrion Gomollon | VNI PCCT may replace true noncontrast after EVAR</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/517/2023-turrion-gomollon-vni-pcct-may-replace-true-noncontrast-after-evar</link>
        <pubDate>Fri, 04 Sep 2026 06:24:59 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">517@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In <strong>110 patients undergoing EVAR surveillance</strong>, including <strong>41 endoleaks</strong>, the authors compared conventional triphasic PCCT (true noncontrast + arterial + venous) with a biphasic strategy in which <strong>virtual noniodine (VNI) images reconstructed from the venous phase replaced the true noncontrast acquisition</strong>.</p><p></p><p>Endoleak detection was essentially preserved with VNI. Sensitivity was identical for each reader (<strong>0.95 vs 0.95</strong> and <strong>0.88 vs 0.88</strong>), while specificity remained similar; interreader agreement was substantial with both TNC (<strong>α = 0.716</strong>) and VNI (<strong>α = 0.756</strong>). Subjective image quality and noise were also comparable.  </p><p></p><p>Replacing TNC with VNI could have reduced radiation exposure by approximately <strong>38%</strong>. A caveat is imperfect calcium preservation: small aneurysm calcifications were erroneously removed in <strong>15/110 patients (14%)</strong>, although this affected endoleak diagnosis in only <strong>one case</strong>, producing a false-positive interpretation.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.ovid.com%2Fjnls%2Finvestigativeradiology%2Ffulltext%2F10.1097%2Frli.0000000000000993%7Ephoton-counting-detector-ct-angiography-for-endoleak" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/BSYZ2OS2QPFH\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:472432,&quot;width&quot;:1000,&quot;height&quot;:575,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FBSYZ2OS2QPFH%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1729,&quot;dateInserted&quot;:&quot;2026-09-04T06:24:37+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2FBSYZ2OS2QPFH%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/BSYZ2OS2QPFH/image.png" alt="image.png" height="575" width="1000" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/BSYZ2OS2QPFH/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/BSYZ2OS2QPFH/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/BSYZ2OS2QPFH/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/BSYZ2OS2QPFH/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/BSYZ2OS2QPFH/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/BSYZ2OS2QPFH/image.png 2000w, https://us.v-cdn.net/6038601/uploads/BSYZ2OS2QPFH/image.png" sizes="100vw" /></a>
    </span>
</span>
<p>Figure 2. Axial CT images at the level of the aortic aneurysm acquired with photon-counting detector CT in a 60-year-old man referred for follow-up imaging after EVAR: (A) true noncontrast images, (B) arterial phase, (C) venous phase with an arrow pointing at the endoleak, and (D) virtual noniodine images reconstructed from venous phase images. </p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Software</strong></p></td><td><p>VA50</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Thoracoabdominal aorta / EVAR surveillance</p></td></tr><tr><td><p><strong>Scan mode</strong></p></td><td><p>QuantumPlus multienergy</p></td></tr><tr><td><p><strong>Acquisition phases</strong></p></td><td><p>True noncontrast, arterial, venous</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>68</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>CARE Dose4D</p></td></tr><tr><td><p><strong>CTDIvol [mGy]</strong></p></td><td><p>TNC 5.1 ± 1.5; arterial 3.74 ± 1.4; venous 4.65 ± 1.4</p></td></tr><tr><td><p><strong>DLP [mGy·cm]</strong></p></td><td><p>TNC 353.3 ± 108.1; arterial 258.9 ± 88.8; venous 320 ± 100</p></td></tr><tr><td><p><strong>Total dose</strong></p></td><td><p>CTDIvol 13.5 ± 3.9 mGy; DLP 932.2 ± 286 mGy·cm</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25</p></td></tr><tr><td><p><strong>Pitch</strong></p></td><td><p>1.2</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>144 × 0.4 mm</p></td></tr><tr><td><p><strong>Reconstruction slice thickness / increment [mm]</strong></p></td><td><p>2.0 / 1.6</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 4</p></td></tr><tr><td><p><strong>TNC reconstruction</strong></p></td><td><p>70-keV VMI, Br36</p></td></tr><tr><td><p><strong>VNI reconstruction</strong></p></td><td><p>70 keV, PureCalcium, Qr36; reconstructed from venous phase</p></td></tr><tr><td><p><strong>Arterial reconstruction</strong></p></td><td><p>55-keV VMI</p></td></tr><tr><td><p><strong>Venous reconstruction</strong></p></td><td><p>60-keV VMI</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iopromide, Ultravist 370 mg I/mL</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>70 mL total</p></td></tr><tr><td><p><strong>Contrast protocol</strong></p></td><td><p>40-mL contrast bolus → 60-mL 1:1 contrast/saline mixture → 20-mL saline chaser</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>4 mL/s</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>Ascending aorta; 140 HU at 90 kV</p></td></tr><tr><td><p><strong>Arterial phase</strong></p></td><td><p>12 s after trigger threshold</p></td></tr><tr><td><p><strong>Venous phase</strong></p></td><td><p>70 s after trigger threshold</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>110 patients; 41 endoleaks (37%)</strong></p></td></tr><tr><td><p><strong>Reader 1 sensitivity / specificity</strong></p></td><td><p>TNC <strong>0.95 / 0.84</strong> vs VNI <strong>0.95 / 0.86</strong></p></td></tr><tr><td><p><strong>Reader 2 sensitivity / specificity</strong></p></td><td><p>TNC <strong>0.88 / 0.98</strong> vs VNI <strong>0.88 / 0.94</strong></p></td></tr><tr><td><p><strong>Interreader agreement</strong></p></td><td><p>TNC <strong>α = 0.716</strong>; VNI <strong>α = 0.756</strong></p></td></tr><tr><td><p><strong>Subjective image quality / noise</strong></p></td><td><p>Both <strong>4 [IQR 4–5]</strong>; no significant difference</p></td></tr><tr><td><p><strong>Potential dose reduction</strong></p></td><td><p><strong>38%</strong> by eliminating the TNC acquisition</p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Turrion Gomollon AM, Mergen V, Sartoretti T, Polacin M, Nakhostin D, Puippe G, Alkadhi H, Euler A. <em>Photon-Counting Detector CT Angiography for Endoleak Detection After Endovascular Aortic Repair: Triphasic CT With True Noncontrast Versus Biphasic CT With Virtual Noniodine Imaging.</em> <strong>Investigative Radiology.</strong> 2023;58(11):816–821. doi:10.1097/RLI.0000000000000993.</p>]]>
        </description>
    </item>
    <item>
        <title>(2026) Kabakus | Is nitroglycerin still necessary for CCTA in the era of PCCT?</title>
        <link>https://connect.siemens-healthineers.com/en/discussion/514/2026-kabakus-is-nitroglycerin-still-necessary-for-ccta-in-the-era-of-pcct</link>
        <pubDate>Thu, 03 Sep 2026 11:07:46 +0000</pubDate>
        <category>Publication protocols</category>
        <dc:creator>Daniel Stromer</dc:creator>
        <guid isPermaLink="false">514@/en/discussions</guid>
        <description><![CDATA[<div><div><p>In 124 patients with CCTA and invasive coronary angiography (ICA) within 30 days, diagnostic performance of PCCT CCTA was similar with and without sublingual nitroglycerin. Per-patient sensitivity was 90.3% vs 90.9%, and NPV was 86.4% vs 88.9%, with no significant differences between groups.</p><p><br />
The non-nitroglycerin group was numerically better for several diagnostic metrics—specificity 80.0% vs 63.3%, PPV 83.3% vs 71.8%, and accuracy 85.7% vs 77.0%—although none reached statistical significance. Likewise, no significant differences were found across LAD, LCx, or RCA analyses, so the findings remain hypothesis-generating rather than practice-changing.</p><p><br />
Nitroglycerin increased left-main attenuation (634 ± 169 vs 546 ± 147 HU, p = 0.029) but did not improve SNR or CNR. The authors also raise the possibility that vasodilation of healthy reference segments may exaggerate percentage stenosis relative to diseased segments, potentially contributing to false-positive CCTA findings.</p></div></div><p><a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1934592526004740" rel="nofollow noopener ugc" role="button">Access publication</a></p><p></p><p></p><span data-embedjson="{&quot;url&quot;:&quot;https:\/\/us.v-cdn.net\/6038601\/uploads\/9NJFQUXN7ZFD\/image.png&quot;,&quot;name&quot;:&quot;image.png&quot;,&quot;type&quot;:&quot;image\/png&quot;,&quot;size&quot;:312399,&quot;width&quot;:713,&quot;height&quot;:507,&quot;displaySize&quot;:&quot;large&quot;,&quot;float&quot;:&quot;none&quot;,&quot;downloadUrl&quot;:&quot;https:\/\/connect.siemens-healthineers.com\/api\/v2\/media\/download-by-url?url=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9NJFQUXN7ZFD%2Fimage.png&quot;,&quot;active&quot;:true,&quot;mediaID&quot;:1728,&quot;dateInserted&quot;:&quot;2026-09-03T11:06:13+00:00&quot;,&quot;insertUserID&quot;:14,&quot;foreignType&quot;:null,&quot;foreignID&quot;:null,&quot;embedType&quot;:&quot;image&quot;,&quot;embedStyle&quot;:&quot;rich_embed_card&quot;}">
    <span>
        <a href="https://connect.siemens-healthineers.com/en/home/leaving?allowTrusted=1&amp;target=https%3A%2F%2Fus.v-cdn.net%2F6038601%2Fuploads%2F9NJFQUXN7ZFD%2Fimage.png" rel="nofollow noopener ugc" target="_blank">
            <img src="https://us.v-cdn.net/6038601/uploads/9NJFQUXN7ZFD/image.png" alt="image.png" height="507" width="713" data-display-size="large" data-float="none" data-type="image/png" data-embed-type="image" srcset="https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=300, width=300/6038601/uploads/9NJFQUXN7ZFD/image.png 300w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=600, width=600/6038601/uploads/9NJFQUXN7ZFD/image.png 600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=800, width=800/6038601/uploads/9NJFQUXN7ZFD/image.png 800w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1200, width=1200/6038601/uploads/9NJFQUXN7ZFD/image.png 1200w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=1600, width=1600/6038601/uploads/9NJFQUXN7ZFD/image.png 1600w, https://us.v-cdn.net/cdn-cgi/image/quality=80, format=auto, fit=scale-down, height=2000, width=2000/6038601/uploads/9NJFQUXN7ZFD/image.png 2000w, https://us.v-cdn.net/6038601/uploads/9NJFQUXN7ZFD/image.png" sizes="100vw" /></a>
    </span>
</span>
<p><strong>Figure 3. </strong>Representative case demonstrating potential nitroglycerin-related overestimation of coronary stenosis severity. A 73-year-old man presenting with chest pain underwent photon-counting CCTA following administration of 0.4 mg sublingual nitroglycerin. (A) Curved multiplanar reformatted CCTA image demonstrates a proximal coronary artery diameter of 3.5 mm, a stenotic segment diameter of 1.8 mm, and a distal reference diameter of 3.0 mm. Based on CCTA findings, the lesion was classified as moderate stenosis (CAD-RADS 3, obstructive disease). (B) Invasive coronary angiography demonstrated slightly smaller reference vessel diameters and a slightly larger residual lumen at the stenotic segment, with measurements of 3.3 mm proximally, 1.9 mm at the stenosis, and 2.7 mm distally. Consequently, the lesion was classified as mild stenosis (non-obstructive disease) by invasive coronary angiography. The discrepancy is likely attributable to nitroglycerin-induced vasodilation of adjacent healthy coronary segments, resulting in approximately 10% enlargement of the reference vessel diameter without substantial dilation of the diseased segment. This differential vasodilatory response increases the apparent percentage stenosis on CCTA and may contribute to overestimation of stenosis severity.</p><p></p><h2 data-id="protocol">Protocol</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Detail</strong></p></th><th><p><strong>Value</strong></p></th></tr><tr><td><p><strong>Scanner</strong></p></td><td><p>NAEOTOM Alpha</p></td></tr><tr><td><p><strong>Scan area</strong></p></td><td><p>Coronary arteries / CCTA</p></td></tr><tr><td><p><strong>Acquisition mode</strong></p></td><td><p>PCCT CCTA</p></td></tr><tr><td><p><strong>Tube voltage [kV]</strong></p></td><td><p>120</p></td></tr><tr><td><p><strong>IQ level</strong></p></td><td><p>64</p></td></tr><tr><td><p><strong>Dose modulation</strong></p></td><td><p>Automated tube current modulation</p></td></tr><tr><td><p><strong>Rotation time [s]</strong></p></td><td><p>0.25</p></td></tr><tr><td><p><strong>Detector slice collimation</strong></p></td><td><p>120 × 0.4 mm</p></td></tr><tr><td><p><strong>Prospective ECG acquisition</strong></p></td><td><p>HR &lt;75 bpm with regular rhythm; acquisition window centered at 60–80% of RR</p></td></tr><tr><td><p><strong>Retrospective ECG acquisition</strong></p></td><td><p>HR &gt;75 bpm or irregular rhythm; full radiation at 30–50% of RR, reduced to 10% during remainder</p></td></tr><tr><td><p><strong>Reconstruction slice thickness [mm]</strong></p></td><td><p>0.4</p></td></tr><tr><td><p><strong>Reconstruction increment [mm]</strong></p></td><td><p>0.3</p></td></tr><tr><td><p><strong>Matrix</strong></p></td><td><p>512 × 512</p></td></tr><tr><td><p><strong>FOV</strong></p></td><td><p>Dedicated cardiac FOV optimized for coronary assessment</p></td></tr><tr><td><p><strong>Kernel</strong></p></td><td><p>Bv44 smooth and Bv60 sharp</p></td></tr><tr><td><p><strong>Iterative reconstruction</strong></p></td><td><p>QIR 3</p></td></tr><tr><td><p><strong>Contrast</strong></p></td><td><p>Iohexol, Omnipaque 350</p></td></tr><tr><td><p><strong>Contrast volume</strong></p></td><td><p>BMI &lt;25: 50–60 mL; BMI 25–30: 60–70 mL; BMI &gt;30: 70–80 mL</p></td></tr><tr><td><p><strong>Injection rate</strong></p></td><td><p>5 mL/s</p></td></tr><tr><td><p><strong>Bolus triggering</strong></p></td><td><p>Descending aorta; monitoring begins 8 s after injection onset; 100-HU threshold</p></td></tr><tr><td><p><strong>Post-trigger delay</strong></p></td><td><p>6 s</p></td></tr><tr><td><p><strong>Mixed bolus</strong></p></td><td><p>30 mL of 50% contrast/saline at 5 mL/s</p></td></tr><tr><td><p><strong>Saline chaser</strong></p></td><td><p>30 mL at 5 mL/s</p></td></tr><tr><td><p><strong>Venous access</strong></p></td><td><p>18-gauge IV</p></td></tr><tr><td><p><strong>Heart-rate control</strong></p></td><td><p>IV metoprolol 5-mg increments every 5 min, maximum 25 mg; target HR &lt;75 bpm</p></td></tr><tr><td><p><strong>Nitroglycerin comparison</strong></p></td><td><p>0.4 mg sublingual nitroglycerin vs no nitroglycerin</p></td></tr></table></div><p></p><h2 data-id="key-results">Key Results</h2><div><table><colgroup><col /><col /><col /></colgroup><tr><th><p><strong>Parameter</strong></p></th><th><p><strong>Main finding</strong></p></th></tr><tr><td><p><strong>Study population</strong></p></td><td><p><strong>124 patients</strong>: 61 nitroglycerin / 63 no nitroglycerin</p></td></tr><tr><td><p><strong>Sensitivity</strong></p></td><td><p><strong>90.3% vs 90.9%</strong>, <em>p</em> = 0.940</p></td></tr><tr><td><p><strong>Specificity</strong></p></td><td><p><strong>63.3% vs 80.0%</strong>, <em>p</em> = 0.160</p></td></tr><tr><td><p><strong>PPV / NPV</strong></p></td><td><p><strong>71.8% / 86.4% vs 83.3% / 88.9%</strong></p></td></tr><tr><td><p><strong>Overall accuracy</strong></p></td><td><p><strong>77.0% vs 85.7%</strong>, <em>p</em> = 0.220</p></td></tr><tr><td><p><strong>Objective image quality</strong></p></td><td><p>LM attenuation higher with nitroglycerin (<strong>634 vs 546 HU</strong>, <em>p</em> = 0.029), but <strong>SNR and CNR unchanged</strong></p></td></tr></table></div><p></p><p><strong>Source:</strong><br />
Kabakus IM, Maisuria DM, Chamberlin JH, Mencken IL, Lopez Rodriguez CG, Sagatelian MM, Burt JR, Baruah D. <em>Is nitroglycerin still necessary for coronary CT angiography in the era of photon-counting CT?</em> <strong>Journal of Cardiovascular Computed Tomography.</strong> 2026. In Press, Corrected Proof. Available online August 22, 2026. doi:10.1016/j.jcct.2026.08.007.</p>]]>
        </description>
    </item>
   </channel>
</rss>
